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ABSTRACT 
Among multiple interconnected pathways for L-Lysine catabolism in pseudomonads, it 
has been reported that Pseudomonas aeruginosa PAO1 employs the decarboxylase and the 
transaminase pathways. However, knowledge of several genes involved in operation and 
regulation of these pathways was still missing. Transcriptome analyses coupled with promoter 
activity measurements and growth phenotype analyses led us to identify new members in L-Lys 
and D-Lys catabolism and regulation, including gcdR-gcdHG for glutarate utilization, dpkA, 
amaR-amaAB and PA2035 for D-Lys catabolism, lysR-lysXE for putative L-Lys efflux and lysP 
for putative L-Lys uptake. The amaAB operon is induced by L-Lys, D-Lys and pipecolate 
supporting the convergence of Lys catabolic pathways to pipecolate. Growth on pipecolate was 
retarded in the gcdG and gcdH mutants, suggesting the importance of glutarate in pipecolate and 
2-aminoadipate utilization. Furthermore, this study indicated links in control of interconnected 
networks of lysine and arginine catabolism in P. aeruginosa.  
Effect of D-amino acids and the genes involved in their metabolism are of great interest 
in both bacteria and mammals. D-Arg utilization in PAO1 requires the coupled dehydrogenases 
DauB and DauA.  In this study, DauB was found to use only L-Arg as its substrate unlike its 
partner dehydrogenase DauA with wide substrate specificity. However, evidence from this study 
and previous studies suggest that the coupled enzymes DauB and DauA are unique for D-Arg 
catabolism.  
The three D-amino acid dehydrogenases DguA, DadA and DauA were found to have 
somewhat limited in vivo substrate specificity compared to that found in vitro tested using 
purified enzymes. Many studies showed that D-amino acids are toxic to bacteria. The ΔdguA, 
ΔdadA and ΔdauA triple mutant had two-fold lower minimum inhibition concentration of 
carbenicillin and tetracycline compared to wild-type PAO1. Both in the wild-type PAO1 and the 
triple mutant, synergy was observed between gentamicin or tetracycline (at concentrations below 
the MIC) and D-amino acids resulting in growth inhibition or reduction, respectively. However, 
no special synergistic or antagonistic effects were observed specifically in the ΔdguA, ΔdadA 
and ΔdauA triple mutant as compared to the wild-type PAO1 when D-amino acids were given in 
combination with antibiotics.  
 
 INDEX WORDS: Pseudomonas, Lysine, Catabolism, Uptake, Regulation, Dehydrogenase, D-
amino acids, Antibiotics, Synergy 
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1 GENERAL INTRODUCTION 
Pseudomonas aeruginosa is a Gram-negative opportunistic human pathogen found widely in the 
environment. It can cause mild infections in healthy individuals and serious life-threatening 
infections in hospitalized patients with low immunity. Its metabolic versatility helps the bacterium 
to thrive in different environments (58). Pseudomonads are known for their ability to utilize a 
number of organic compounds as carbon and nitrogen sources due to the presence of a large 
number of catabolic pathways. Understanding the regulation of these catabolic pathways helps 
gain insight into the strategies employed by this pathogen to survive in human hosts under 
conditions of varied nutrient availability and cause disease. 
 
1.1 L-Lysine catabolism in P. aeruginosa 
 
Unlike other pseudomonads, P. aeruginosa cannot utilize Lysine efficiently as a nutrient source. 
Multiple and interconnected catabolic pathways exist for the utilization of lysine in microbes. As 
shown in Figure 1.1, L-lysine is catabolized via the monooxygenase pathway in Pseudomonas 
putida, while in P. aeruginosa it is mainly mediated via the decarboxylase pathway (5, 49, 51). 
Expression of the lysine decarboxylase LdcA was found inducible by the arginine regulator ArgR 
and L-arginine but not L-lysine in P. aeruginosa PAO1 (5), making this initial step in the proposed 
pathway as a bottleneck for L-Lysine catabolism in this organism. Cadaverine, the product of 
LdcA, is further degraded to 5-aminovalerate through the γ-glutamylation pathway for polyamine 
catabolism that is controlled by PauR (7, 65). Both monooxygenase and decarboxylase pathways 
converge at 5-aminovalerate, which is then converted to glutarate by a pair of transaminase and 
semialdehyde dehydrogenase enzymes encoded by the gabDT operon (7, 50). Glutarate is 
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proposed to produce acetyl-CoA that can enter the Krebs cycle (42), and glutaryl-CoA 
dehydrogenase enzyme (an enzyme in glutarate catabolism) activity has been reported in crude 
extracts of P. aeruginosa (15). However, none of the genes for glutarate catabolism and its 
regulation have been characterized in Pseudomonas. 
 
1.2 Lysine racemase and D-lysine catabolism in P. aeruginosa 
 
The presence of a lysine (Lys) racemase has been reported in P. putida to convert L-Lys to D-Lys 
(48, 49). The catabolic pathway for D-Lys catabolism in this organism (Figure 1.1) has been 
proposed to degrade D-Lys to 2-aminoadipate, which is then further degraded to α-ketoglutarate 
to enter the Krebs cycle. Several genes encoding enzymes of this proposed pathway in P. putida 
KT2440 have been identified, including PP3590 for D-Lys transaminase, PP3596 for D-Lys 
dehydrogenase, dpkA for Δ1-Piperideine-2-carboxylate reductase (38, 48, 49), amaB and amaA in 
conversion of pipecolate to 2-aminoadipate (48). In the case of P. aeruginosa, it does not possess 
the lysine racemase; however, L-Lys catabolism can potentially be connected to the D-Lys 
pathway via an arginine-pyruvate transaminase AruH that can take L-Lys as substrate (5, 64). One 
early report suggested the presence of another route through L-lysine 6-amino transferase to make 
L-pipecolate which again could possibly convert into glutarate (15). In P. aeruginosa, the alpha 
amino group of D-Lys can be deaminated by the FAD-dependent D-amino acid dehydrogenase 
DauA (33). It was not clear how D-Lys catabolism was operated in this organism due to very 
limiting information about potential players in the catabolic pathway. 
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Figure 1.1 Lysine catabolism in P. aeruginosa PAO1 and P. putida KT2440.  
 
Pathways in P. aeruginosa PAO1 and P. putida KT2440 were indicted in solid black arrows and 
dashed gray arrows, respectively. Genes that are subjected to control by transcriptional regulators 
ArgR, PauR, GcdR, DauR, and AmaR were labeled in different colors. LYS, lysine; CAD, 
cadaverine; AMV, δ-aminovalerate; GA, glutaric acid; KAH, α-keto-ε-aminohexanoate (keto-
lysine); ΔP2C, Δ1-piperideine-2-carboxylate; L-PIP, L-pipecolate; ΔP6C, Δ1-piperideine-6-
carboxylate; 2-AAS, 2-aminoadipate semialdehyde; 2-AAP, 2-aminoadipate; 2-KAP, 2-
ketoadipate; α-KG, α-ketoglutarate. 
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1.3 D-Amino acids in human health and disease 
 
A few decades ago D-amino acids were not believed to be present in mammals, until large 
amounts of free D-amino acids were detected in mammalian tissues (1). D-amino acids in 
humans can be derived either by racemization of the cognate L-forms, from the food ingested or 
from the intestinal normal flora (39).  D-Serine (D-Ser) was shown to be associated with 
neurotransmission, cell migration, and neurotoxicity. Elevated levels of D-Ser have been 
detected in animal models of amyotrophic lateral sclerosis while a deficiency can trigger seizures 
(54, 1). Also, D-Ser has been implicated to have a role in Alzheimer’s, a disease characterized by 
a decline in learning and memory. The neuronal networks of the hippocampus, center for 
memory, is affected by aging. Activation of N-Methyl-D-aspartate subtype of glutamate 
receptors (NMDAR) which regulates the strength of synaptic transmission is affected by D-
serine related pathways (like lack of racemase to convert L-serine to D-form) (2). Elevated levels 
of D-Ser and D-Asp have implications in the possible development of Schizophrenia (1 & 13).  
 
1.4 Significance of D-amino acids in bacteria 
 
Amino acids exist as L and D-enantiomers. Proteins are composed of L-amino acids 
predominantly. However, the D-amino acids are also part of living organisms and are important 
for various cellular functions. Even though some D-amino acid containing peptides were 
discovered in bacteria, the wider importance of D-amino acids was not well studied or understood 
until a few decades ago (25). Recent studies showed that D-amino acids have important regulatory 
roles in the bacterial world in addition to serving as growth nutrient, being incorporated into the 
peptidoglycan layer (3) or inhibiting the bacterial spore germination (21). Many groups have 
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demonstrated that D-amino acids can be detrimental to the cell. Certain D-amino acids like D-Met 
were shown to be incorporated into the peptidoglycan and also inhibit peptidoglycan synthesis and 
cross-linking (3). D-amino acids in combination with β-lactam antibiotics were reported to alter 
cell morphology (4). Bacillus subtilis was shown to produce a mixture of D-Leu, D-Met, D-Tyr 
and D-Trp to prevent biofilm formation and also disassemble biofilms (26). Lam et al, (28) found 
unusual D-amino acids in Vibrio cholerae and Bacillus subtilis that seemed to modify the cell wall 
in stationary phase cultures. Excess D-amino acids were shown to be released into the environment 
and could serve as a means of communication to control and coordinate growth among the bacteria 
living in that environment (26). D-amino acids given in combination with antimicrobials has a 
synergistic effect on biofilm dispersal in some isolates of P. aeruginosa and Staphylococcus 
aureus (52). 
 
1.5 Bacterial biosynthesis of D-amino acids 
L-amino acids being predominant in nature, serve as the substrates for D-amino acid biosynthesis 
by racemization. Amino acid racemases are of two types: pyridoxal 5ʹ phosphate (PLP) 
dependent and PLP independent enzymes. In the PLP dependent enzymes like the alanine and 
serine racemases, the α-carbon of the amino acid is first deprotonated. The anionic form thus 
formed is stabilized by the PLP moiety bound to the racemase after which the anionic form is re-
protonated on the opposite side generating the other enantiomer of the same amino acid. In the 
case of PLP independent enzymes like the glutamate and proline racemases, even though they 
follow a similar mechanism as above they do not need a cofactor to stabilize the intermediate 
carbanion (67, 4). In addition to racemization from L-to-D form, D-amino acids can also be 
synthesized by D-amino acid transaminases using their respective keto acids and the amino 
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group donated by D-alanine. In many gram-positive bacteria like Bacillus, Geobacillus and 
Staphylococcal species D-glutamate (D-Glu) was found to be synthesized by D-amino acid 
transaminase enzymes. (47, 16, 30). In P. aeruginosa, the arginine: pyruvate transaminase AruH 
was shown to convert L-Lys to α-keto-ε-aminohexanoate (64, 5). This is one of the links 
connecting the L- and D-Lys pathway in P. aeruginosa PAO1.  
 
1.6 Degradation of D-amino acids in bacteria 
D-amino acids can serve as a nutrient source to support bacterial growth when provided in 
excess. Some organisms have genes to directly catabolize the D-amino acids while others require 
them to be converted into the L-forms before they can be catabolized by enzymes like 
transaminase and amidases (11, 12, 59). The first step in D-amino acid catabolism usually 
involves D-amino acid oxidases, dehydrogenases or aminotransferases to remove the amino 
group. The oxidase and dehydrogenase enzymes require cofactors like FAD+ or NAD+ as 
electron acceptors while the aminotransferases or transaminases can directly transfer the amino 
group from the α-amino acid to a α-keto acid (64, 31, 19, 35, 20).  
 
1.7  D-amino acid catabolism in P. aeruginosa PAO1 
P. aeruginosa has an enormous catabolic capacity to utilize a variety of D-amino acids as carbon 
and/or nitrogen sources. As described below, five different enzymes have been reported to 
facilitate the utilization of D-amino acids in this organism:  
 
1.7.1 Arginine dehydrogenases, DauBA.  
The utilization of D-arginine (D-Arg) in this organism is facilitated by the coupled arginine 
dehydrogenases, DauA and DauB (31). DauA catalyzes oxidative deamination of D-Arg into 2-
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ketoarginine and ammonia. DauB then uses 2-ketoarginine and ammonia as substrates to convert 
them into L-arginine (L-Arg) in the presence of NADPH or NADH (Figure 1.2). This D-to-L 
racemization is an essential step for the utilization of D-Arg in this organism, taking advantage 
of four different catabolic pathways of L-Arg. However, it is not known if these two enzymes 
form a complex and if DauB also shares the wide substrate specificity of its partner enzyme 
DauA. Mutation of dauA abolishes growth on both D-Arg (carbon and nitrogen source) and D-
Lys (as nitrogen source) while mutation of dauB abolishes growth on D-Arg (as carbon source). 
Enzymatic reactions using purified His-tagged protein showed that DauA can utilize a number of 
D-amino acids as the substrate generating their respective keto-acid and ammonia, while the in 
vitro substrate specificity of DauB is yet to be studied (31). In Chapter 2 of this study, we 
characterized the DauB enzyme and studied its substrate specificity using purified enzyme.    
 
 
Figure 1.2 Arginine racemization by DauBA. 
 
1.7.2 D-alanine dehydrogenase, DadA.  
The dadRAX locus encodes the genes for alanine (Ala) catabolism and regulation in P. 
aeruginosa (19).  DadX is an amino acid racemase that converts L-alanine to D-alanine while 
DadA is a dehydrogenase that catalyzes the breakdown of D-alanine into pyruvate and ammonia 
using FAD as a cofactor (see Figure 1.3). DadR is the transcriptional activator of dadAX operon 
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in the presence of L-alanine. DadA can utilize all D-amino acids as the substrate except for D-
Glu and D-Gln as determined by the enzymatic reactions using purified His-tagged DadA. 
However, in vivo studies using the dadA mutant revealed that only the utilization of Ala, His, 
Phe, Ser, Thr and Val (all tested as a nitrogen source in glucose minimal medium) are dependent 
on DadA (19).  
 
 
Figure 1.3 Alanine racemization and catabolism by DadXA. 
 
1.7.3 D-glutamate dehydrogenase, DguA.  
The divergent dguR-dguABC gene cluster was shown to participate in D-Glutamate (D-Glu) and 
D-Glutamine (D-Gln) catabolism and regulation (20). Both dguA and dguR mutants completely 
lost the ability to grow on D-Glu and grew very poorly on D-Gln as the sole source of carbon or 
nitrogen. DguR is the transcriptional activator of the dguABC operon in the presence of 
exogenous D-Glu and D-Gln. The dguA gene encodes a FAD-dependent D-amino acid 
dehydrogenase which deaminates D-Glu to generate α-ketoglutarate and ammonia in the 
presence of FAD as the cofactor (Figure 1.4).  The dguB gene encodes a putative enamine/imine 
deaminase of the RidA family, but its role in D-Glu utilization is not known yet. The dguC gene 
encodes a periplasmic solute-binding protein, but was found not essential for D-Glu utilization. 
Instead, the acidic L-amino acid transported AatJQMP was found to be induced and essential for 
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D-Glu utilization. Enzymatic assays using crude cellular extracts in vitro showed that DguA has 
dehydrogenase activity against D-Glu, D-Pro, and D-Gln. (20).   
 
 
 
Figure 1.4 D-Glutamate catabolism by DguA. 
 
1.7.4 D-serine dehydratase, DsdA.  
D-Serine dehydratase DsdA is an orphan gene in the genome of P. aeruginosa PAO1. This gene 
has no regulatory elements resulting in no activation even in the presence of D-Ser. However, 
when over expressed it can support the growth of PAO1 on D-Ser as the sole source of carbon 
and nitrogen. Even though the D-alanine dehydrogenase DadA can utilize D-Ser as the substrate, 
it can only support growth on D-Ser as nitrogen source but not as a carbon source. These two 
enzymes have a very different enzymatic reaction. DsdA converts D-Ser into ammonia and 
pyruvate while DadA converts it into ammonia and β-hydroxy pyruvate. The DsdA is a PLP 
dependent enzyme (35). In E. coli, excess D-Ser can be toxic as it inhibits the biosynthesis of 
pantothenate and L-Ser. Pantothenate is essential for the biosynthesis of coenzyme A (10). DsdA 
rescues the cell from the effects of D-Ser by catabolizing it into pyruvate and ammonia. In E. 
coli, the dsdCXA locus encodes for the D-serine deaminase (dsdA), the D-serine inner membrane 
transporter (dsdX) and a divergently transcribed LysR-type transcriptional activator (dsdC). In 
addition, transcriptional activation of dsdXA gene is subject to catabolite repression and requires 
cyclic AMP and the cyclic AMP activator protein (37, 41).  
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Figure 1.5 D-Serine catabolism by DsdA and DadA. 
 
1.7.5 D-Hydroxyproline dehydrogenase, LhpBEF.  
L-Hydroxyproline (L-Hyp), a non-proteingenic amino acid, is found in mammals and also in 
bacteria. In mammals, it is formed by post-translational modifications by the action of prolyl 4-
hydroxylase and is an important constituent of collagen. In some bacteria, during the 
biosynthesis of secondary metabolites like actinomycin and etamycin, L-Hyp is synthesized from 
L-proline (29). L-Hyp can serve as a good carbon and nitrogen source in P. aeruginosa. This 
requires the L-Hyp to be converted into D-Hyp first by the epimerase LhpA. Then the D-Hyp is 
oxidized by the D-Hyp dehydrogenase LhpBEF into Δ1-pyrroline-2-carboxylate reductase and 
subsequently into α-ketoglutarate by the deaminase LhpC and aldehyde dehydrogenase LhpG 
(62, 34). 
 
1.8 Research Strategy 
My research project was focused mainly on identifying the missing players in Lysine utilization 
in P. aeruginosa. Previous research from our lab showed that L-Lysine is catabolized via the 
decarboxylase pathway to yield cadaverine which then is converted into 5-aminovalerate via the 
γ-glutamylation pathway followed by its conversion into glutarate. Even though glutarate is 
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believed to be catabolized to yield intermediates of the Krebs cycle, the key players in this 
pathway are not known yet. In P. aeruginosa, the genes in D-lysine catabolic pathway and its 
connections to the L-lysine catabolism are far from being clear. This is the first report to identify 
the genes involved in glutarate catabolism, their regulation and also show that the D- and L-
Lysine pathway are indeed connected in P. aeruginosa PAO1. All this work is discussed in 
Chapter 2.  
 
Previous studies from our lab showed that racemization by the coupled DauA and DauB 
reactions is essential for D-arginine utilization in P. aeruginosa PAO1.  They also showed that 
DauA, a catabolic D-arginine dehydrogenase, exhibits a wide substrate specificity in in vitro 
enzymatic studies. However, the DauB enzyme, an anabolic L-arginine dehydrogenase, has not 
been characterized. It is also not known if DauB reciprocates the substrate specificity exhibited 
by its partner dehydrogenase DauA. In this dissertation, we characterized the DauB enzyme and 
studied its substrate specificity as discussed in Chapter 3. 
 
Even though the three known D-amino acid dehydrogenases (DauA, DadA, and DguA) were 
characterized previously, their substrate specificity in vitro and the effect of these respective 
mutants in the utilization of various D-amino acids differ greatly. This is possibly due to 
substrate redundancy as demonstrated by in vitro enzymatic studies. In order to identify the true 
or in vivo substrate specificity of each of these dehydrogenase enzymes, we designed a study. 
We constructed a triple mutant strain devoid of all these three known dehydrogenases discussed 
above and verified the utilization of various D-amino acids as the sole carbon and or nitrogen 
sources by complementing one dehydrogenase gene at a time. Further, as discussed above, the 
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availability of D-amino acids from nature is scarce and emerging research shows that D-amino 
acids have various regulatory roles. We also tested the hypothesis that the triple mutant devoid of 
three D-amino acid dehydrogenases will be more sensitive to antibiotics in the presence of D-
amino acids. All this work is discussed in Chapter 4.  
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2 MOLECULAR CHARACTERIZATION OF LYSR-LYSXE, GCDR-GCDHG, AND 
AMAR-AMAAB OPERONS FOR LYSINE EXPORT AND CATABOLISM: A 
COMPREHENSIVE LYSINE CATABOLIC NETWORK IN PSEUDOMONAS 
AERUGINOSA PAO1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was partially published by Sai Madhuri Indurthi, Han-Ting Chou and Chung-Dar Lu in 
“Molecular Characterization of lysR-lysXE, gcdR-gcdHG, and amaR-amaAB Operons for Lysine 
Export and Catabolism: A Comprehensive Lysine Catabolic Network in Pseudomonas aeruginosa 
PAO1”. Microbiology. 2016 May; 162(5):876-88. 
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2.1 Introduction 
 
P. aeruginosa is a Gram-negative opportunistic human pathogen found widely in the environment. 
It can cause mild infections in healthy individuals and serious life-threatening infections in 
hospitalized patients with low immunity. Its metabolic versatility helps the bacterium to thrive in 
different environments (58). Pseudomonads are known for their ability to utilize a number of 
organic compounds as carbon and nitrogen sources due to the presence of a large number of 
catabolic pathways. Understanding the regulation of these catabolic pathways helps gain insight 
into the strategies employed by this pathogen to survive in human hosts under conditions of varied 
nutrient availability and cause disease. 
 
2.1.1 L-lysine catabolism:  
P. aeruginosa cannot utilize Lysine efficiently as a nutrient source (8). It was reported that this 
organism employs the decarboxylase pathway for L-lysine catabolism. The expression of the 
lysine decarboxylase LdcA is inducible by the arginine regulator ArgR and L-arginine but not by 
L-lysine in P. aeruginosa PAO1 (5), making this initial step in the proposed pathway a bottleneck 
for L-Lysine catabolism in this organism. Cadaverine, the product of LdcA, is further degraded to 
5-aminovalerate through the γ-glutamylation pathway for polyamine catabolism (7, 66). Then 5-
aminovalerate is converted to glutarate by 4-aminobutyrate transferase and succinate-
semialdehyde transferase enzymes (7, 50). Glutarate is proposed to be converted into acetyl-CoA 
that can enter the Krebs cycle (42), and glutaryl-CoA dehydrogenase enzyme (an enzyme in 
glutarate catabolism) activity has been reported in crude extracts of P. aeruginosa (15). However, 
none of the genes for glutarate catabolism and its regulation have been characterized in 
Pseudomonas. In addition to this, the genes for lysine uptake are also not known.  
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2.1.2 D-lysine catabolism:  
P. aeruginosa can utilize D-Lys only as a nitrogen source but not as a carbon source. In the case 
of P. putida which can utilize D-Lys as a carbon and nitrogen source, D-Lys catabolism was 
reported to be mediated by the aminoadipate pathway converting it into 2-aminoadipate and further 
into α-ketoglutarate to enter the Krebs cycle. In addition, the presence of a lysine racemase has 
been reported in P. putida to convert L-Lys to D-Lys (49, 51) making the aminoadipate pathway 
an alternate to L-Lys catabolism. In the case of P. aeruginosa, it does not possess the lysine 
racemase; however, L-Lys catabolism can potentially be connected to the D-Lys pathway via an 
arginine: pyruvate transaminase AruH (5, 64). L-Lys can also be taken up by L-lysine 6-amino 
transferase to make L-pipecolate (L-Pip) which again could convert into glutarate (15). In P. 
aeruginosa, the FAD-dependent D-amino acid dehydrogenase DauA can deaminate the alpha 
amino group of D-Lys (33). It was not clear how D-Lys catabolism was operated in this organism 
due to very limiting information about potential players in the catabolic pathway. 
 
2.1.3 Research Strategy 
Many of the intermediate compounds in the proposed lysine catabolic pathways in P. aeruginosa 
PAO1 can serve as better sources of carbon and nitrogen than lysine itself. It was known that lysine 
catabolism is composed of multiple modules of biochemical reactions, and the expression of each 
module is controlled by a specific intermediate compound and its corresponding regulators. To 
gain a better understanding of the interconnections of L-Lys and D-Lys catabolism in P. 
aeruginosa, we conducted transcriptome analysis to identify several possible missing links and 
new players, and these thus identified members were subjected to further characterization to tie in 
their physiological functions and regulatory mechanisms into an integrated metabolic network. 
16 
 
 
2.2 Materials and methods 
2.2.1 Strains and growth conditions.  
Bacterial strains used in this study were listed in Table 2.1. Luria–Bertani (LB) medium was used 
for bacterial growth with the following supplements as required: ampicillin at 100 µg/ml and 
carbenicillin at 100 µg/ml for both E. coli and P. aeruginosa. Minimal medium P (MMP) 
supplemented with specific carbon sources and nitrogen sources was used for the growth of P. 
aeruginosa (16). Unless specified, mutant strains with a single lesion by transposon insertion used 
in this study (Table 2.1) were obtained from the stock center at University of Washington, Seattle 
(24).  
 
Table 2.1 Bacterial strains and plasmids used in this study. 
Strain or 
plasmid 
Genotype or description Source or reference 
E. coli   
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 
λ– thi- 
1 gyrA96 relA1 
Bethesda 
Research 
Laboratories 
TOP10 F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1araD139 Δ(ara leu) 7697 galU galK 
rpsL 
(StrR) endA1 nupG 
Invitrogen 
 
P. aeruginosa 
  
PAO1 Wild type (18) 
PW1815 gcdG-F01::ISlacZ/hah (24) 
PW1817 gcdH-A02::ISphoA/hah (24) 
PW1819 gcdR-C02::ISphoA/hah (24) 
PW2858 PA1026-G12::ISphoA/hah (24) 
PW2859 amaA-E05::ISphoA/hah (24) 
PW2862 amaB-B10::ISlacZ/hah (24) 
PW3259 dpkA-D05::ISphoA/hah (24) 
PW4475 dhcR-G02::ISlacZ/hah (24) 
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PW4478 atoB::ISlacZ/hah (24) 
PW4480 PA2002-D03::ISlacZ/hah (24) 
PW4481 bdhA-H08::ISphoA/hah (24) 
PW4520 PA2035-D05::ISphoA/hah (24) 
PW8087 PA4181-F03::ISlacZ/hah (24) 
PW8089 PA4182-B01::ISlacZ/hah (24) 
PW8366 lysR-F10::ISphoA/hah (24) 
PW8368 lysX-G02::ISlacZ/hah (24) 
PW8370 lysE-A07::ISphoA/hah (24) 
PW9274 amaR-E05::ISlacZ/hah (24) 
PW9379 PA4979-G11::ISphoA/hah (24) 
PW9381 PA4980-B07::ISphoA/hah (24) 
PW9382 PA4981-C03::ISphoA/hah (24) 
PAO5720 aruH::Tcr (5) 
PAO501 argR::Gmr (44) 
PAO5508 aruS::Tcr (65) 
PAO5509 aruR:: Tcr (65) 
MJ 27 Parental strain of MJ99 (61) 
MJ 99 ΔdhcAB (61) 
   
Plasmids   
pQF50  
 
bla lacZ transcriptional fusion vector (14) 
pLYS 1-5 lysX::lacZ fusion of pQF50 This study 
pGCD 1-5 gcdH::lacZ fusion of pQF50 This study 
pAMA1-8 amaA::lacZ fusion of pQF50 This study 
pPA4181 PA4181::lacZ fusion of pQF50 This study 
pLYSP lysP::lacZ fusion of pQF50 This study 
pBAD-HisE Vector modified from pBAD-HisC (31) 
pGCDR-HisC 6His-tagged GcdR protein expression vector This study 
pLYSR-HisC 6His-tagged LysR protein expression vector This study 
pAMAR-HisC 6His-tagged AmaR protein expression vector This study 
Tcr, tetracycline resistance; Gmr, gentamicin resistance 
 
2.2.2 Transcriptome analysis.  
Two independent sets of P. aeruginosa PAO1 cultures were grown aerobically in MMP media 
with 10 mM L-Glu with 10 mM L-Lys, cadaverine (Cad), 5-amino valerate (AMV), glutaric acid 
(GA), D-Lys or 5 mM L-pipecolate (L-Pip). Cells in the exponential growth phase were harvested, 
and RNA samples were extracted from cells with RNeasy Plus Mini Kit (Qiagen). Following the 
protocol of Affymetrix, cDNA was synthesized, fragmented, and labeled. Labeled cDNA was used 
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for GeneChip Microarrays with P. aeruginosa Genome Array. Data were collected and analyzed 
by comparing gene expression under each test condition to that by L-Glu following the same 
parameters as described previously (6). Data were processed by Microarray Suite 5.0 software, 
normalizing the absolute expression signal values of all chips to a target intensity of 500. Only 
genes showing consistent expression profiles in duplicates were selected for further analysis. All 
GeneChip data used by this study have been deposited in NCBI database (GEO accession number 
GSE75502). 
 
2.2.3 Construction of gene promoter::lacZ fusions.  
For the construction of promoter lacZ fusions, the regulatory regions of the genes were amplified 
from the genomic DNA of P. aeruginosa PAO1 by PCR with specific primer pairs as following: 
GCD1-F and GCD1-R for pGCD1; LYS1-F and LYS1-R for pLYS1; AMA1-F and AMA1-R for 
pAMA1; PA4181-F and PA4181-R for pPA4181; and LYSP-F and LYSP-R for pLYSP. Purified 
PCR products were digested with specific restriction enzymes and ligated to pQF50 (13) digested 
with the same enzymes before they were transformed into E. coli DH5α. The positive clones were 
selected on LB plates containing ampicillin, and the nucleotide sequence of the inserts was 
confirmed by DNA sequencing. Plasmids with serial deletions from the full-length inserts were 
constructed by the same approach with specific primers. 
 
2.2.4 Cloning, expression, and purification of hexahistidine-tagged LysR and 
GcdR.  
The structural genes of lysR, gcdR and amaR were amplified by PCR from the genomic DNA of 
P. aeruginosa PAO1 using the following primer pairs: LysR-F and LysR-R for lysR; GcdR-F and 
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GcdR-R for gcdR; and AmaR-F and AmaR-R for amaR. The resulting PCR products were digested 
with specific restriction enzymes and cloned into the expression vector pBAD-HisE (31) so that 
the C-terminus of LysR, GdhR and AmaR was fused in-frame with the His6-tag while the N-
terminus is preceded by a ribosome binding site and an arabinose-inducible promoter in the 
plasmid. The resulting plasmids, pLYSR, pGCDR, and pAMAR were introduced into E. coli 
Top10 (Invitrogen). For overexpression of LysR, GcdR and AmaR proteins, the recombinant 
strains of E. coli were grown in LB medium containing ampicillin at 37 °C. For over expression, 
0.2 % L-arabinose (w/v) was added to the culture when the OD600 was approximately 0.5-0.6. 
After 4h of vigorous shaking at 18 °C, cells were harvested by centrifugation and stored at -80 °C 
until use.   
 
The cell pellets were suspended in phosphate buffer A (20 mM Na2HPO4, 0.5 M NaCl, 20 mM 
imidazole, pH 7.5) with PMSF (1 mM) as a protease inhibitor and the cells were ruptured by an 
Aminco French press. Cell debris was removed by centrifugation at 30,000 g for 30 min. The 
supernatant was applied to a HisTrap HP column (GE Health Care), and the His-tagged LysR was 
eluted at 20-60 % buffer B and His-tagged GcdR was eluted at 40-70 % buffer B (20 mM 
Na2HPO4, 0.5 M NaCl, 1 M imidazole, pH 7.5). The target fractions were analyzed by SDS-
PAGE, pooled and concentrated using an Amicon Ultra-15 centrifugal filter unit (molecular mass 
cut-off, 30 kDa; Millipore) to change the buffer to 20 mM Tris-HCl (pH 7.5). Protein concentration 
was determined by the method of Bradford (27). In the case of AmaR, all the protein was in the 
pellet fraction (insoluble), and nothing was eluted in the fractions collected from the nickel column 
after purification.  
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Table 2.2 Primers used in this study. 
Primer name Primer sequence Reference 
GCD1-F 5ʹ-ATGCGGATCCGGGTCAGGGACAACTCCTCC-3ʹ This study 
GCD1-R 5ʹ-ATGCAAGCTTCCGGTCTCGCCCATCTCGCG-3ʹ This study 
LYS1-F 5ʹ-ATGCGGATCCGCAGGCGTTCCGGGGCACC-3ʹ This study 
LYS1-R 5ʹ-ATGCAAGCTTCCGTGGCGAAGGCGGCGGTCAG-3ʹ This study 
AMA1-F 5ʹ-ATGCGGATCCGTCGGCGTTC GCAGGGTG-3ʹ This study 
AMA1-R 5ʹ-ATGCGGATCCGCCCCTCCAGTCGCAC GCA-3ʹ   This study 
PA4181-F 5ʹ-ATGCGGATCCGCGCAGGGACTCCAGCAGGT-3ʹ This study 
PA4181-R 5ʹ-ATGCAAGCTTGCGCTCTACGGCGCGGCCG-3ʹ This study 
LysR-F 5ʹ-ATCTCATGATTTTGTTCGACTACAAGTTGCTCG CCGC-3ʹ This study 
LysR-R 5ʹ-GGGGCCTGACACCCGCACCAAGCC-3ʹ This study 
GcdR-F 5ʹ-ATCTCATGAGACGCAAGATCCCTTCCACCG-3ʹ This study 
GcdR-R 5ʹ- GGGGCCCAGCCCGTTGGCCTCGC-3ʹ This study 
AmaR-F 5'-ATCGGATCCATGCTGAACAAACGCCGCCTGC-3' This study 
AmaR-R 5'-GGGAACCGGGCCGTGGCGCGTC-3' This study 
LYSP-F 5'-ATGCGGATCCCGCCCATCGCCTGTCCGGAA-3' This study 
LYSP-R 5'-ATGCAAGCTTCGCCGGAGCCCATGAACAGC-3' 
 
This study 
 
2.2.5 Electrophoretic mobility shift assays (EMSA).  
The DNA probes (2 ng) were allowed to interact with different concentrations of GcdR or LysR 
in the reaction buffer containing 50 mM Tris-HCl (pH 7.5 or pH 8.5, respectively), 50 mM KCl, 
1 mM EDTA, 5 % (v/v) glycerol, 4 mM dithiothreitol (DTT) and 200 µg/ml acetylated bovine 
serum albumin. After incubation for 10 min at room temperature, 20 µl of each reaction mixture 
was loaded on a polyacrylamide gel (6 %) in Tris/borate-EDTA buffer (pH 8.7). The gels were 
stained with SYBR Gold solution (Invitrogen) for 20 min, washed twice with deionized H2O, and 
scanned. 
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2.3 Results 
 
2.3.1 Transcriptome profiling.  
Many of the intermediate compounds in the proposed lysine catabolic pathways in P. aeruginosa 
PAO1 can serve as better sources of carbon and nitrogen than lysine itself. We hypothesized that 
lysine catabolism is composed of multiple modules of biochemical reactions, and each module is 
controlled by a specific intermediate compound and its corresponding regulatory mechanism at 
the genetic level. To get a more detailed understanding of lysine catabolism and regulation, DNA 
microarray experiments were conducted to get a snapshot of gene expression during exponential 
growth phase in the wild type strain PAO1 grown in glutamate (L-Glu) minimal medium 
supplemented with L-Lys, CAD, AMV, GA, D-Lys or L-Pip. The expression profiling under each 
test condition was compared to that of L-Glu and the genes that displayed over three-fold induction 
with significant signal levels in duplicates were selected for further analyses. 
 
Listed in Table 2.3 is a selected group of genes that was subjected to more detailed characterization 
in this study. Some genes that passed the initial screening parameters have been characterized in 
our previous reports as members of the γ-glutamylation pathway for CAD and polyamine 
catabolism (7, 66), and hence were intentionally omitted from the list. Therefore in this table, we 
mainly focused on genes that are either new or less characterized members in the Lys metabolic 
network. In particular, this study characterized three operons (lysXE-R, gcdHG-R and amaAB-R) 
that play significant roles in Lys utilization in PAO1, apart from some other genes that are activated 
by L-Lysine.  
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Table 2.3 Genes selected from DNA microarray analysis for L-Lys catabolism. 
PA ID* Gene 
Name 
Signal Intensity§ Description 
Glu L-Lys CAD AMV GA D-Lys L-Pip  
PA0446 gcdG 266 1263 1698 2294 11738 615 2256 Acyl-coA transferase 
PA0447 gcdH 242 9746 7201 9183 19218 1572 4215 Glutaryl-coA 
dehydrogenase 
PA0448 gcdR 115 83 69 91 156 56 58 Transcriptional regulator 
PA1027 amaA 139 1230 197 238 81 4858 6105 NAD-dependent aldehyde 
dehydrogenase 
PA1028 amaB 75 483 231 144 136 2460 3521 FAD-dependent 
oxidoreductase 
PA1252 dpkA 113 205 465 279 105 285 252 L-malate dehydrogenase 
PA1998 dchR 126 284 351 322 165 221 238 Transcriptional regulator 
PA1999 dchA 54 72 215 371 7081 161 153 Dehydrocarnitine CoA 
transferase 
PA2000 dchB 63 156 380 624 5767 157 165 Dehydrocarnitine CoA 
transferase 
PA2001 atoB 101 165 175 259 3763 95 73 Acetyl-CoA 
acetyltransferase 
PA2002  38 165 185 136 542 95 103 Conserved hypothetical 
protein 
PA2003 bdhA 137 402 411 375 1387 315 257 3-hydroxybutyrate 
dehydrogenase 
PA2035  51 198 167 35 82 1659 2974 Probable decarboxylase 
PA4181  169 5721 432 385 191 344 416 Hypothetical protein 
PA4182  234 8589 423 457 282 276 250 Transcriptional factor 
PA4363 lysR 54 59 35 104 45 65 28 Inhibitor of chromosome 
initiation IciA 
PA4364 lysX 38 2448 125 30 60 182 162 Hypothetical protein 
PA4365 lysE 33 2304 181 111 37 89 115 Lysine efflux permease 
PA4914 amaR 187 321 299 337 137 239 142 Transcriptional regulator 
PA4976 aruH 130 630 130 53 111 180 149 Arginine: pyruvate 
transaminase 
PA4981 lysP 38 5855 189 39 61 100 93 Amino acid permease 
* The PA ID numbers were from the PAO1 genome annotation project 
(WWW.pseudomonas.com). 
§ GeneChip raw data were mean values of two independent sets of cultures. 
 
2.3.2 Growth phenotypes.  
Mutants of various genes under study were obtained from the transposon mutant library stock 
center (University of Washington). These mutants were checked for growth on L-Lys, CAD, 
AMV, GA, L-Pip or L-Arg as the sole source of carbon and nitrogen on minimal medium plates 
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and the growth was recorded as in Table 2.4. In the case of glutarate which can only serve as a 
carbon source, ammonium chloride (0.5 %) was included in the growth medium as the nitrogen 
source. 
 
Table 2.4 Growth phenotype of various P. aeruginosa knockout mutants. 
PA ID Strain Genotype Transposon 
direction§ 
Growth with indicated supplement 
L-Arg L-Lys CAD AMV GA L-Pip 
 PAO1 Wild-type NA ++ ++ ++ ++ ++ ++ 
PA0446 PW1815 gcdG R ++ - - - - - 
PA0447 PW1817 gcdH R ++ - - - - - 
PA0448 PW1819 gcdR F ++ - - - - NT 
PA1026 PW2858  R ++ ++ ++ ++ ++ ++ 
PA1027 PW2859 amaA R ++ + ++ ++ ++ - 
PA1028 PW2862 amaB F ++ + ++ ++ ++ - 
PA1252 PW3259 dpkA R ++ ++ ++ ++ ++ NT 
PA1998 PW4475 dhcR R ++ ++ ++ ++ ++ ++ 
PA2001 PW4478 atoB F ++ ++ ++ ++ ++ ++ 
PA2002 PW4480  R ++ ++ ++ ++ ++ ++ 
PA2003 PW4481 bdhA R ++ ++ ++ ++ ++ ++ 
PA2035 PW4520  R ++ + ++ ++ ++ - 
PA4181 PW8087  F ++ ++ ++ ++ ++ NT 
PA4182 PW8089  R ++ ++ ++ ++ ++ NT 
PA4363 PW8366 lysR F ++ +++ ++ ++ ++ NT 
PA4364 PW8368 lysX F ++ +++ ++ ++ ++ NT 
PA4365 PW8370 lysE F ++ +++ ++ ++ ++ NT 
PA4914 PW9274 amaR F ++ + ++ ++ ++ - 
PA4976 PAO5503 aruH  ++ ++ ++ ++ ++ NT 
PA4979 PW9379  F ++ ++ ++ ++ ++ NT 
PA4980 PW9381  R ++ ++ ++ ++ ++ NT 
PA4981 PW9382 lysP R ++ +/- ++ ++ ++ NT 
 *MJ27 Wild-type  ++ ++ ++ ++ ++ ++ 
PA1999-2000 *MJ99 dhcAB  ++ ++ ++ ++ ++ ++ 
Cells from two independent colonies were grown in MMP with the compounds indicated as the 
sole source of carbon and nitrogen (20 mM) except for GA (10 mM) where 0.5 % NH4Cl was 
added as the nitrogen source. Aerobic growth at 37 °C was followed for 4 days and recorded as 
follows under each growth condition: +++, better growth than wild-type PAO1;++, same growth 
as wild-type PAO1;+, weaker growth than wild-type PAO1;+/2, very poor growth compared 
with wild-type PAO1; 2, no growth even after 4 days. NT, Not tested; NA, not applicable. 
Significant changes in the growth phenotype were marked in gray. The PW strains of transposon 
insertion mutants were obtained from the University of Washington Pseudomonas stock center. 
MJ27 and MJ99 were gifted by Dr. M. J. Wargo (University of Vermont). 
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*PA ID numbers were from the PAO1 genome annotation project 
(http://www.pseudomonas.com). †Transposon direction refers to the absolute direction of the 
transposon and transcriptional direction of a strong internal promoter carried by the transposon in 
the genome. F, forward; R, reverse. Forward is oriented parallel to increasing nucleotide base 
number and PA gene annotation number.  
‡MJ27 is the parental strain of MJ99 and the comparison is made between these two and not the 
wild-type PAO1 above. 
 
 
It was found that mutants of gcdG, gcdH or gcdR were completely defective for growth on L-Lys, 
CAD, AMV, GA and L-Pip but grew normally on L-Arg. Based on the genome annotation, the 
divergent gcdR-gcdHG operon (Figure 2. 4a) encodes a transcriptional regulator, the glutaryl-CoA 
dehydrogenase, and a putative acyl-CoA transferase, respectively. The results of growth phenotype 
analyses support the proposed functions of these genes in glutarate utilization. Surprisingly, it was 
found that these mutants cannot grow on L-Pip that is the intermediate compound in D-lysine 
catabolism and was proposed to be converted into 2-aminoadipate (Figure 1.1). The results would, 
therefore, support the route for converting 2-aminoadipate into glutarate, but not α-ketoglutarate 
as has been suggested by early reports (46, 49).  
 
In the proposed pathway, conversion of L-Pip into 2-aminoadipate requires two sequential 
reactions catalyzed by AmaB and AmaA. Indeed the amaA and amaB mutants were completely 
defective for growth on L-Pip, supporting their role in L-Pip and hence D-Lys catabolism. 
Furthermore, these two mutations also affected growth on L-Lys, suggesting the presence of a 
metabolic flow that is branched out from L-Lys catabolism (Figure 1.1). A similar pattern of 
growth phenotypes was also observed for the mutant of amaR encoding a putative transcriptional 
regulator of the amaAB operon. 
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Among genes that were induced specifically by L-lysine, PA4981 (lysP) encodes a putative amino 
acid permease, and the lesion in this gene exhibited strong growth defect on L-Lys. We also 
compared the growth phenotype of the lysP mutant and the wild-type strain PAO1 on glucose 
minimal medium with different nitrogen sources, including ammonium, L-Arg, D-Arg, L-Lys, and 
D-Lys. The apparent growth defect of the lysP mutant was observed with D-Lys and L-Lys but 
not D-Arg and L-Arg. It suggested the significant role of LysP as a potential Lys transporter. 
 
On the contrary, among all mutants tested, it was found that the lysR, lysX, and lysE mutants grew 
better than the parental strain on L-Lys. The lysX gene codes for a protein of unknown function 
while the lysE gene codes for a putative amino acid exporter of the LysE/ArgO family, showing 
45% sequence identity to the arginine exporter ArgO and the lysine exporter LysO of E. coli (40, 
45). Upstream of the lysXE operon, the divergent lysR gene was annotated as iciA (60) by the 
genome project, and the encoding transcriptional regulator exhibited 41% sequence identity to 
ArgP of E. coli in control of ArgO expression. As supported by other lines evidence described 
below, the enhanced growth on L-Lys of the lysR mutant was very likely due to its activation effect 
on lysXE expression. 
 
2.3.3 Induction of the gcdHG promoter.  
To study regulation of the gcdHG operon, a gcdH::lacZ transcriptional fusion plasmid (pGCD1; 
Figure. 2.3a) was constructed and introduced into wild-type PAO1 as described in Materials and 
Methods. The ability of various compounds to activate the gcdH promoter was tested. Consistent 
with the results of GeneChip analysis (Table 2.3), a similar pattern of promoter induction by L-
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Lys, CAD, AMV, GA, D-Lys and L-Pip was observed in PAO1 harboring pGCD1 by 
measurements of β-galactosidase activities (Figure 2.1).  
 
 
 
Figure 2.1 Expression profile of the gcdH promoter in vivo.  
The gcdH promoter activity was monitored by measuring β-galactosidase activity in the wild-type 
(WT) PAO1 and its mutants harboring the pGCD1 plasmid. The cells were grown in L-Glu (10 
mM) minimal medium in the presence of various compounds as indicated above (10 mM). Specific 
activity values represent the mean ± SD of three measurements for each growth condition. L-Glu, 
L-glutamate; L-Lys, L-lysine; CAD, cadaverine; AMV, 5-aminovalerate; GA, glutarate; D-Lys, 
D-lysine; L-Pip, L-pipecolate. 
 
Among compounds tested, exogenous glutarate exerts the strongest effect on promoter induction, 
suggesting glutarate as the potential effector compound for promoter activation. To test this 
hypothesis, the levels of gcdH promoter activation by glutarate were also measured in the gcdG 
and gcdR mutants harboring pGCD1. In comparison to the level in the wild-type PAO1, this 
promoter was activated more than five-fold higher in the gcdG mutant, which was expected to 
accumulate glutarate inside the cell without the acyl-CoA transferase activity. On the contrary, this 
promoter showed no sign of induction in the gcdR mutant (Figure 2.1). These results support the 
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hypothesis of GcdR as the transcriptional activator of the gcdHG operon in response to glutarate 
as the signal molecule. 
 
2.3.4 DNA binding activity of GcdR.  
The results of growth phenotype analysis and promoter measurements indicated the potential 
function of GcdR as the transcriptional regulator of the gcdHG operon in glutarate catabolism. 
Recombinant GcdR with a hexahistidine tag at its carboxyl terminus was expressed and purified 
from a strain of E. coli as described in Materials and Methods. This recombinant GcdR was used 
to demonstrate its interactions with the gcdH promoter region by electrophoretic mobility shift 
assays (EMSA). As shown in Figure 2.2, GcdR forms nucleoprotein complexes with DNA 
fragments covering the gcdHG promoter region carried by pGCD1. Although the presence of 
glutarate in the binding reaction did not cause any change in affinity of GcdR to the probe DNA, 
it seemed to favor nucleoprotein complexes that migrate slower on the gel in comparison to those 
without glutarate. 
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Figure 2.2 Demonstration of GcdR-DNA interactions.  
The gcdH promoter regions as in pGCD1, pGCD3 or pGCD4 were used as the probe. The purified 
GcdR-His(6) of the concentrations indicated was used with or without 5 mM glutaric acid (GA) 
as indicated in each reaction. F, free probe; C, nucleoprotein complexes. Locations of free probes 
and major nucleoprotein complexes are also marked with arrows. 
 
In order to further narrow down the GcdR binding site, shorter probes carried by pGCD2, pGCD3, 
pGCD4 and pGCD5 (Figure 2.3a) were generated and tested for interactions with GcdR (Figure 
2.2). The result of serial deletions led us to identify a region of 30 bp that may carry the GcdR 
operator site as described below. It was also supported by the promoter activity measurements 
(Figure 2.3b) carrying the same series of promoter fragments as in the EMSA. Site-directed 
mutagenesis of the proposed GcdR operator in pGCD4 or absence of the proposed GcdR operator 
in pGCD5 resulted in complete abolishment of glutarate-dependent induction of the gcdH 
promoter activity. 
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2.3.5 Multiple sequence alignment of gcdHG promoters in Pseudomonas.  
Information from comparative genomics indicated that gcdR-gcdHG genes are highly conserved 
among various species of Pseudomonas (www.pseudomonas.com). Multiple sequence alignment 
was conducted for the gcdHG regulatory regions from representative species which revealed a 
highly conserved sequence motif. In accordance with the results of promoter analysis and gel shift 
assays shown in Figure 2.1 and 2.2, it appeared that the sequence motif (5’-
GTGAGAAAATAGCAC-3’) 109 bp upstream of the gcdH initiation codon might be a potential 
candidate of GcdR operator. A second conserved sequence motif was found downstream of the 
proposed GcdR operator site (Figure 2.3d). However, this site was excluded as the GcdR operator 
site as binding of GcdR to the pGCD1 probe was retained after digestion with the restriction 
enzyme EcoRI, which is located in the middle of the second conserved sequence motif (data not 
shown). Site-directed mutagenesis of the first three bases in the proposed GcdR operator from 
GTG in pGCD3 to ACA in pGCD4 resulted in complete loss of GcdR binding in vitro (Figure 2.2) 
and loss of promoter activation in vivo (Figure 2.1). 
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Figure 2.3 Identification of GcdR binding site on the gcdH promoter region.  
(a) Schematic presentations of the divergent gcdR-gcdGH operons and constructs of the 
gcdH::lacZ fusions. Five plasmids of serial deletions in the regulatory regions were labeled with 
plasmid names.  
(b) Measurements of β-galactosidase activity from fusion plasmids and summary of GcdR binding 
activity with the gcdH regulatory region carried by these plasmids. L-Glu, L-glutamate; GA, 
glutaric acid. Binding of GcdR to the region was indicated by “+” signs and no binding was 
indicated by “-“.  
(c) The nucleotide sequence of the gcdH regulatory region. Locations of 5’-end for pGCD2, 
pGCD3, pGCD4 and pGCD5 and ATG initiation codons for gcdH and gcdR were indicated with 
arrow signs and labels. The -10 and -35 sequences for the putative promoter were also labeled. 
The proposed GcdR operator site was in bold italicized letters with double underline. S.D., Shine-
Dalgarno sequence for ribosomal binding.  
(d) Multiple sequence alignments for the putative GcdR operators in the gcdH regulatory regions 
of representative species of Pseudomonas in the following order: P. aeruginosa (PAO1), P. 
denitrificans (ATCC13867), P. mendocina (NK01), P. fluorescens (Pf01), P. entomophila (L48), 
P. stutzeri (CCUG29243), P. fulva (12-X), and P. putida (KT2440).  
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2.3.6 Induction of lysXE by L-Lys.  
As described above, lysE was proposed to encode the putative L-Lys exporter, and it forms a 
putative operon with the upstream lysX of unknown function. To test the expression profiling of 
lysXE, a lysX::lacZ transcriptional fusion plasmid (pLYS1) was constructed and introduced into 
wild-type PAO1. The ability of various compounds to activate this promoter was tested. As shown 
in Figure 2.4, it was found that this promoter was induced by L-Lys only, consistent with the 
results of the DNA microarray experiments (Table 2.3). 
 
 
Figure 2.4 Expression profile of the lysX promoter in vivo.  
The lysXE promoter activity was monitored by measuring β-galactosidase activity in the wild-type 
& mutant PAO1 harboring the pLYS1 plasmid. The cells were grown in L-Glu alone (20 mM) or 
L-Glu + L-Lys (10 mM each) minimal medium. Specific activity values represent the mean ± SD 
of three measurements for each growth condition. L-Glu, L-glutamate; L-Lys, L-lysine; CAD, 
cadaverine; AMV, 5-aminovalerate; GA, glutarate; L-Arg, L-arginine. 
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The activity of lysX promoter was also measured in various mutants in order to understand the 
regulatory mechanism of the lysXE operon. It was found that lysine-dependent induction of the 
lysX promoter was completely abolished in strain PW8366 carrying a lesion on lysR (Figure 2.4). 
On the contrary, the level of induction by L-Lys in the lysX or lysE mutant was even higher than 
that in the wild-type strain PAO1. These results supported the proposed functions of LysE and 
LysR as L-Lys exporter and lysine-responsive transcriptional activator, and suggested a link of 
LysX to the lysine export system. 
 
2.3.7 DNA binding activity of LysR.  
LysR was overexpressed and purified with a hexahistidine tag at its carboxyl terminus as described 
in Materials and Methods. This recombinant LysR was used to demonstrate its interaction with the 
lysX promoter region by EMSA. LysR alone was able to bind to a DNA fragment carrying the lysX 
promoter region in pLYS1 to form nucleoprotein complexes (C1 and C2; Figure 2.5). We also 
tested the potential effects of two amino acids, L-Lys and L-Arg, on LysR-DNA interactions. 
However, only minimal effects can be detected by the presence of these two amino acids in vitro, 
which cannot be explained for the observed effects in vivo.  
 
In an attempt to identify the LysR operator sites, multiple sequence alignments were conducted 
with the lysX promoter sequences from PAO1 and representative strains from different gene 
clusters. As shown in Figure 2.6c, a conserved sequence motif was found in this regulatory region 
that could potentially be the Lys operator site. This finding is further supported by the loss of LysR 
binding in EMSA with lysX promoter DNA fragments lacking this motif in pLYS4 and pLYS5 
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(Figure 2.6b) and also by the lack of transcriptional activation in these two plasmids in the presence 
of L-Lys in the wild-type PAO1 in Figure 2.6b. 
 
Figure 2.5 Demonstration of LysR-DNA interactions.  
(a) Promoter DNA as in pLYS1 or pPA4181 was used as the probe. The purified LysR-His(6) of 
indicated concentrations was used with or without 5 mM L-lysine (L-Lys) or L-arginine (L-Arg) 
in the reaction.  
(b) Promoter DNA as in pLYS2, pLYS3, pLYS4 or pLYS5 was used as the probe. All reactions 
were carried out in the presence of 5 mM L-Lys. F, free probe; C1 and C2, nucleoprotein 
complexes.  
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Figure 2.6 Identification of LysR operator on the lysXE promoter region.  
(a) Schematic presentations of the divergent lysR-lysXE operons and constructs of the lysX::lacZ 
fusions. Five plasmids of serial deletions in the regulatory regions were labeled with plasmid 
names.  
(b) Measurements of β-galactosidase activity from fusion plasmids and summary of LysR binding 
activity with the lysXE regulatory region carried by these plasmids. L-Glu, L-glutamate; L-Lys, L-
lysine. Binding of LysR to the region was indicated by “+” signs and no binding was indicated by 
“-“.  
(c) The nucleotide sequence of the lysXE regulatory region. Locations of 5’-end for pLYS3, 
pLYS4, and pLYS5 and ATG initiation codons for gcdH and gcdR were indicated with arrow signs 
and labels. The -10 sequence for the putative promoter were also labeled. The proposed LysR 
operator site was in bold italicized letters with double underline.  
(d) Multiple sequence alignments for the putative LysR operators in the lysXE regulatory regions 
of representative species of Pseudomonas in the following order: P. aeruginosa (PAO1), P. 
denitrificans (ATCC13867), P. mendocina (NK01), P. fluorescens (Pf01), P. entomophila (L48), 
P. stutzeri (CCUG29243), P. fulva (12-X), and P. putida (KT2440). The proposed LysR site was 
marked with divergent arrows. The ATG initiation codon for PAO1 was marked with double lines, 
and single line with other species. The dashed line denotes the ribosomal binding site. Also shown 
on the right side of this panel were the two types of gene organizations for lysine exporter and 
transcriptional regulator in these species of Pseudomonas.  
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2.3.8 Induction of the amaAB promoter.  
From transcriptome analysis, amaAB of P. aeruginosa PAO1 was found inducible to a comparable 
level by D-Lys and L-Pip. This operon was also induced by L-Lys but to a relatively low level. To 
substantiate this finding, the amaA::lacZ transcriptional fusion plasmid (pAMA1) was constructed 
and introduced into the wild type strain PAO1 to analyze the expression profiling of this promoter. 
As shown in Figure 2.7, the amaA promoter was induced by L-Lys, D-Lys, and L-Pip, consistent 
with the DNA microarray experiments (see Table 2.3).  
 
 
Figure 2.7 Expression of the amaA promoter in vivo.  
The amaA promoter activity was monitored by measuring β-galactosidase activity in the wild-type 
and mutant PAO1 harboring the pAMA1 plasmid. The cells were grown in glutamate minimal 
medium in the presence of various compounds as indicated above (10 mM). Specific activity 
values represent the mean ± standard deviation of three measurements for each growth condition. 
L-Glu, L-glutamate; L-Lys, L-lysine; D-Lys, D-lysine; L-Pip, L-pipecolate. 
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Divergent from the amaAB operon, the PA1026 gene codes for a putative transcriptional 
elongation factor of the GreA/GreB family (www.pseudomonas.com). However, the knockout 
mutant of this gene grew normally on all compounds tested in this study (Table 2.4), and it did not 
affect the expression profiling of the amaA promoter (data not shown). These results led us to 
exclude PA1026 as the regulatory gene of amaAB. In the case of P. putida KT2440, the PP5259 
gene encoding a transcriptional regulator of the LysR family was also divergently transcribed from 
the amaAB operon in this bacterium (49). Based on sequence similarity we found PA4914 of PAO1 
as the possible orthologue of PP5259. As shown in Figure 2.7, activation of the amaAB promoter 
by L-Lys or D-Lys was lost completely in the PA4914 knockout mutant (PW9274) suggesting that 
PA4914 is the transcriptional activator of the amaAB operon. We, therefore, designated PA4914 
as amaR. Consistent with its role in activation of amaAB, the amaR mutant exhibited the same 
pattern of growth defect on L-Lys and L-Pip as the amaA and amaB mutants (Table 2.4). 
 
2.3.9 Induction of the amaAB operon by L-Lys was abolished in the PA1252 
mutant.  
Although L-Lys catabolism in P. aeruginosa PAO1 is mainly through the decarboxylase pathway, 
it can also be channeled into the D-Lys pathway via the transaminase pathway (3). As shown in 
Figure 1.1, L-Lys and D-Lys catabolism may converge at α-keto-ε-aminohexanoate (aka keto-
lysine), which then spontaneously cyclizes to form Δʹ-piperidine-2-carboxylate. This convergence 
was further supported by our findings that L-Lys is able to induce the amaAB operon (Table 2.3 
and Figure 2.7), which encodes enzymes for the subsequent degradation of Δʹ-piperidine-2-
carboxylate to 2-aminoadipate. One missing link in the converged pathway is the enzyme 
converting Δʹ-piperidine-2-carboxylate to L-Pip. On potential candidate of this enzyme was 
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encoded by the PA1252, based on its sequence homology to DpkA (PP3591) of P. putida KT2440 
that has been previously shown to catalyze this reaction in D-Lys and D-Pro catabolism (25, 33). 
From the results of transcriptome analysis (Table 2.3), the PA1252 gene was found not inducible 
by L-Lys, D-Lys, or L-Pip. However, activation of the amaA promoter by L-Lys, and D-Lys was 
completely lost in the PA1252 mutant (Figure 2.7), supporting its role in the conversion of Δʹ-
piperidine-2-carboxylate to L-Pip and thereby in Lys catabolism in PAO1. 
 
2.3.10 DNA binding activity of AmaR and the potential AmaR operator site.  
Even though the cloning and expression of AmaR-HisC were successful, the purification of this 
protein was not successful. SDS-PAGE analysis showed that all the target protein is in the pellet 
fraction (inclusion bodies) and none was seen in the fractions collected during purification. The 
protein purification was repeated again under the same conditions. The collected fractions that 
are free of other major proteins were pooled and checked on SDS-PAGE to see if there was any 
small amount of AmaR-HisC. No protein was detected on the gel after staining.  Since the 
protein purification was not successful, the plan to test the DNA binding of AmaR was 
dismissed. However, based on multiple sequence alignment of amaAB regulatory regions from 
representative pseudomonas species, a potential AmaR binding site was identified (as shown in 
Figure 2.8c). A total of eight plasmids of serial deletions were tested for the promoter activation 
using β-galactosidase assay. However, we could not confirm the potential AmaR binding site 
which was possibly disrupted in pAMA6 and hence had no promoter activation (see Figure 2.8b) 
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Figure 2.8 Identification of AmaR operator on the amaAB promoter region.  
(a) Schematic presentations of the amaAB operon and constructs of the amaA::lacZ fusions. A 
total of eight plasmids of serial deletions in the regulatory regions were labeled with plasmid 
names. (b) Measurements of β-galactosidase activity from fusion plasmids. (c) The nucleotide 
sequence of the amaA regulatory region. Locations of the 5’ ends for pAMA2, pAMA3, 
pAMA4, pAMA5, pAMA6, pAMA7, and pAMA8 are indicated by arrowheads and the ATG 
initiation codon for amaA is underlined and bolded. (d) Multiple sequence alignment of amaA 
regulatory regions of representative species P. aeruginosa (PAO1), P. syringae (BRIP39023), P. 
fluorescens (AU1382) and P. putida (KT2440). 
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2.3.11 The PA4181-PA4182 operon of unknown functions was inducible by L-Lys.  
The putative PA4181-PA4182 operon was identified from transcriptome analysis as genes 
specifically induced by L-Lys (Table 2.3). To substantiate this finding, the PA4181::lacZ fusion 
plasmid (pPA4181) was constructed and introduced into wild-type PAO1. The ability of various 
compounds to activate this promoter was tested. It was found that this operon was induced by L-
Lys only (Figure 2.9) consistent with the DNA microarray experiments. Genome annotations 
suggested the presence of a B3/B4 tRNA-binding domain in the PA4181 peptide, and the PA4182 
peptide was predicted as transcriptional factor with an FMN-binding domain. To test if the 
induction effect of L-Lys on the PA4181 promoter depends on PA4182 or lysR, the pPA4181 
plasmid was introduced into the PA4181 and lysR mutants to measure the promoter activities. The 
results showed that promoter activation of pPA4181 by L-Lys was completely lost in the lysR 
mutant indicating that lysR is the transcriptional activator of this operon. The promoter region of 
PA4181 carried by the pPA4181 plasmid was used as the probe to test the binding of lysR as 
described in Materials & Methods. Indeed purified His-tagged LysR did bind to this DNA probe 
of PA4181 as shown in Figure 2.5a, confirming the results of promoter activation experiments 
(Figure 2.9). Similar to results with the lysE probe, at least two nucleoprotein complexes (C1 and 
C2) can be observed by EMSA, and the addition of L-Lys to the binding reaction also led to the 
preferential formation of C1 complex (Figure 2.5a).  
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Figure 2.9 Expression of the PA4181 promoter in vivo.  
The promoter activity of PA4181was monitored by measuring β-galactosidase activity in the wild-
type & mutant PAO1 harboring the pPA4181 plasmid. The cells were grown in glutamate minimal 
medium in presence of various compounds as indicated above (10 mM).  Specific activity values 
represent the mean ± standard deviation of three measurements for each growth condition. L-Glu, 
L-glutamate; L-Lys, L-lysine; CAD, cadaverine; AMV, 5-aminovalerate; GA, glutaratic acid. 
 
2.3.12 Induction of lysP promoter.  
The lysP is an orphan gene next to the aruSR two component system on the P. aeruginosa 
genome. This gene was found to be induced by L-Lys during transcriptome analysis (Table 2.3). 
Further, growth phenotype results (Table 2.4) showed that the lysP mutant grew very poorly on 
L-Lys suggesting the importance of lysP for L-Lys uptake in PAO1. Previous studies showed 
that lysP is induced by L-Arg and ArgR is a repressor for lysP. Promoter activity assay was 
conducted in vitro using pLYSP in wild-typw PAO1 and various mutants. It was found that lysP 
was induced by L-Arg and L-Lys and the promoter activity was increased by several folds in 
PAO501 (Figure 2.10) confirming that ArgR is indeed a transcriptional repressor of lysP.  The 
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expression of lysP was not affected in PW8366 indicating that LysR is not a transcriptional 
regulator of this gene. Further, it was observed that lysP activation was completely lost in aruS 
and aruR mutants. The aruSR two component system was shown to be induced by L-Arg. The 
uptake system lysP being under the control of two arginine regulatory systems explains for the 
poor growth of PAO1 on L-Lys suggesting that the uptake is one bottleneck in L-Lys utilization.  
 
 
Figure 2.10 Expression of lysP promoter in vivo. 
The promoter activity of lysP was monitored by measuring β-galactosidase activity in the wild-
type & mutant PAO1 harboring the pLysP plasmid. The cells were grown in glutamate minimal 
medium in presence of various compounds as indicated above (10 mM).  Specific activity values 
represent the mean ± standard deviation of three measurements for each growth condition. L-Glu, 
L-glutamate; L-Lys, L-lysine; L-Arg, L-arginine; D-Lys, D-lysine. 
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2.4 Discussion 
2.4.1 Glutarate catabolism plays a pivotal role in lysine catabolism.  
L-Lys catabolism in P. aeruginosa is mainly mediated by the lysine decarboxylase pathway, which 
converts L-Lys into glutarate. Previous reports from our group have characterized all genes 
encoding enzymes in this process. In the current study, the gcdHG operon was identified to play 
essential roles in glutarate catabolism from the results of transcriptome analysis (Table 2.3) and 
growth phenotype analysis (Table 2.4). Genome annotations predicted GcdH as glutaryl-CoA 
dehydrogenase and GcdG as putative acyl-CoA transferase (www.pseudomonas.com). In 
conjunction with our results presented here, this information supported GcdG and GcdH as 
glutaryl-CoA transferase and glutaryl-CoA dehydrogenase that catalyze two contiguous reactions 
to convert glutarate into crotonyl-CoA (42, 46). 
 
Not only essential for L-Lys catabolism, it was found in our study that the gcdG and gcdH mutants 
cannot grow on L-Pip, suggesting that L-Pip is also degraded via glutarate. L-Pip is an intermediate 
compound of D-Lys catabolism (Figure 1.1), followed by the generation of 2-aminoadipate. 
Enzymes and their coding genes that are involved in the conversion of L-Pip to 2-aminoadipate 
have been identified in P. putida (34) and P. aeruginosa PAO1 in this study. However, information 
regarding degradation of 2-aminoadipate to glutarate was still missing. One possible player in this 
process might be PA2035 encoding a TPP-dependent decarboxylase. The PA2035 gene found 
inducible by D-Lys and L-Pip in transcriptome analyses (Table 2.3), and the knockout mutant of 
PA2035 completely lost the ability to grow on L-Pip (Table 2.4) suggesting that PA2035 is 
essential for L-Pip utilization in PAO1. 
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2.4.2 The GcdR transcriptional activator responds to its signaling compound 
glutarate.  
Several lines of evidence support the conclusion that GcdR is the transcriptional activator for the 
gcdH promoter. First, the gcdR mutant cannot grow on L-Lys or its catabolic intermediates Cad, 
AMV or GA. Second, induction of the gcdH promoter by exogenous GA was completely abolished 
in the gcdR mutant. Third, the purified recombinant GcdR protein binds to the regulatory region 
of the gcdH promoter. A combination of serial deletion analysis and multiple sequence alignments 
led us to identify a highly conserved sequence motif among species of Pseudomonas as the GcdR 
operator site in the gcdH promoter region (Figure 2.3). 
 
2.4.3 Lysine uptake and export are two bottlenecks for growth on L-Lys.  
P. aeruginosa PAO1 can utilize L-Lys as the sole source of carbon and nitrogen. However, it has 
been observed that under this growth condition with L-Lys, the wild-type strain PAO1 spent a very 
long lag phase before resuming logarithmic growth. We have reported that the lysine 
decarboxylase LdcA was subjected to induction by L-arginine and the ArgR transcriptional 
regulator (5), and hence considered the lack of lysine-dependent induction of ldcA as the bottleneck 
for L-Lys catabolism. 
 
In the current study, we found that the presence of a lysine-inducible exporter posed another major 
limiting factor for growth on L-Lys. From the transcriptome analysis, the lysXE genes were found 
to be induced specifically by exogenous L-Lys and this was confirmed by promoter activity 
measurements. The lysXE genes encode an uncharacterized protein with one Pfam ATC3 domain 
and a putative lysine efflux protein, respectively, while the divergent lysR gene encodes a 
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transcriptional regulator. The lysE gene shares 45 % sequence similarity with the arginine exporter 
ArgO of E. coli. Knockout mutants of lysR, lysX, and lysE were found to grow much better than 
the wild-type PAO1 on MMP agar with L-Lys as the sole source of carbon and nitrogen. In liquid 
media, the lysR, lysX and lysE mutants had a much shorter lag-phase compared with the wild-type 
PAO1. Also, the estimated generation time of these mutants was shorter (9-13 h) than that of the 
WT (19 h). We believe that the shorter lag phase and generation time observed in lysR, lysX, and 
lysE mutants was due to the lack of a functional lysine exporter, resulting in higher intracellular 
concentrations of L-Lys compared with the wild-type PAO1.  
 
Previous studies from our lab showed that the AotJQMP transporter for L-Arg uptake is also 
induced by L-Lys. The first enzyme in L-Lys catabolism is under the control of ArgR, an arginine 
responsive regulator, and L-Arg. These two things lead to the belief that L-Lys uptake is also 
mediated by the AotJQMP transporter. However, growth phenotype results in this study showed 
that the lysP mutant almost lost the ability to grow on L-Lys as the sole carbon and nitrogen source 
indicating its importance in L-Lys uptake. Further, we found that lysP promoter was induced by 
both L-Arg and L-Lys. This induction effect by L-Arg was enhanced several folds in the argR 
mutant confirming its repression effect on lysP transcription. In addition, we found that the 
induction of lysP was completely abolished in the aruS and aruR mutants which are again known 
to respond to exogenous L-Arg. This suggests that the uptake via an L-Arg responsive and ArgR 
regulated transporter also is another reason for the poor growth of PAO1 on Lysine. 
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2.4.4 The LysR transcriptional activator responds to its signaling compound L-
Lys. 
Several lines of evidence support the conclusion that LysR is the transcriptional activator for the 
lysX promoter. First, the lysR mutants grow much better than the wild-type PAO1 (possibly due to 
the absence of LysX and LysE).  Second, the induction of the lysX promoter by exogenous L-Lys 
was completely abolished in the lysR mutant. Third, the purified recombinant LysR protein binds 
to the regulatory region of the lysX promoter. The LysR operator site in the lysX promoter region 
was also deduced from the results of serial deletions and multiple sequence alignments (Figures 
2.4 & 2.6)  
 
2.4.5 Interconnected regulatory systems for ArgR and Lysine metabolism.  
Findings from the current study and previous reports indicated the presence of a sophisticated 
regulatory network of Arg and Lys uptake and catabolism in Pseudomonas. As shown in Figure 
2.11, there are at least four transcriptional regulators that respond to Arg and Lys – LysR (L-Lys), 
AruSR (L-Lys and L-Arg), ArgR (L-Arg) and DauR (D-Lys and D-Arg). P. aeruginosa is well 
equipped to grow more efficiently on Arg than on Lys, with the ArgR regulator in response to L-
Arg as the major player to control the entire arginine network (33, 36), including the AotJQMP 
transporter for L-Arg and L-Lys uptake. Furthermore, the ArgR extended its influence to Lys 
catabolism through its control on ldcA for L-Lys decarboxylase (5), dauBAR-dauT for D-Lys/D-
Arg dehydrogenase and uptake, and potentially on lysP and aruH for L-Lys uptake and L-Lys/L-
Arg aminotransferase (65). The overall efficiency of L-Lys catabolism was further dampened by 
the presence of L-Lys exporter LysXE that is subjected to positive regulation by the LysR regulator 
in response to L-Lys as depicted in this study. The physiological significance of this observed 
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nutritional preference for Arg over Lys in Pseudomonas was a very intriguing question for future 
investigation. 
 
 
 
Figure 2.11 Schematic summary of arginine and lysine interconnected regulatory networks.  
The transcriptional regulators along with their signal compounds and the genes under their 
control are connected with either an arrow for positive effect ‘┬’ or for negative effect. 
 
 
In conclusion, we have characterized several new members of the L-Lys and D-Lys catabolic 
pathways and their regulatory elements, including gcdR-gcdHG for glutarate utilization, dpkA, 
amaR-amaAB and PA2035 for D-Lys catabolism, lysR-lysXE for putative L-Lys efflux, lysP 
(PA4981) for putative L-Lys uptake. Integration of these new data with information from previous 
reports led us to discover an inducible amino acid exporter as a bottleneck for L-Lys catabolism 
and to decipher a tightly interconnected metabolic network for D-Lys and L-Lys in Pseudomonas. 
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3 CHARACTERIZATION OF ANABOLIC L-ARGININE DEHYDROGENASE DAUB 
OF PSEUDOMONAS AERUGINOSA PAO1 
3.1 Introduction 
 
Proteins are composed of L-amino acids predominantly. However, the D-amino acids are also part 
of living organisms and are important for various cellular functions. D-amino acids are essential 
components of bacterial cell walls (53). D-serine and D-aspartate were shown to be involved in 
cellular aging and neural signaling, respectively (41, 42). Amino acid racemases catalyze the 
conversion of L-forms of the amino acids into the D-forms for these purposes. Some D-amino 
acids can be used for growth by bacteria when in excess with the help of these racemases. P. 
aeruginosa PAO1 has been shown to possess coupled dehydrogenases DauA and DauB that 
facilitate the racemization of D-arginine (D-Arg) to L-arginine (L-Arg) (31). The dauA gene 
encodes for the enzyme catabolic D-arginine dehydrogenase while dauB gene encodes for the 
enzyme anabolic L-arginine dehydrogenase.  The proposed biochemical reaction of these coupled 
enzymes is as follows: 
 
 
Figure 3.1 Schematic representation of arginine racemization. 
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DauA can utilize a number of D-amino acids as the substrate in addition to D-Arg to generate 
their respective keto-acid and ammonia (33) as shown in Figure 3.2  
 
Figure 3.2 Substrate specificity of DauA. 
The substrate specificity of DauA as determined from the D-amino acid dehydrogenase activity 
of the purified enzyme. The enzyme activity towards D-Arg was taken as 100 %, and with 
respect to it, the relative activity towards each D-amino acid was calculated. This figure is 
adapted from Li et al, 2010 (33). 
 
DauB is a bidirectional enzyme that can use either 2-ketoarginine + NH4Cl in a forward reaction 
or L-Arg in a reverse reaction with NADH/NADPH or NAD+/NADP+ as the cofactors 
respectively. In this research, we attempted to characterize the enzyme DauB. I hypothesized 
that, if DauA and DauB are coupled enzymes, then DauB should also be able to utilize other D-
amino acids as a substrate like it partner enzyme DauA. We also attempted to characterize the 
DauB enzyme kinetics.  
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3.2 Materials and methods 
 
3.2.1 Bacterial strains, plasmids and growth conditions.  
P. aeruginosa PAO1 wild-type (8), E. coli DH5α (Bethesda Research Laboratories) and Top10 
(Invitrogen) were used in this study. Both E. coli and P. aeruginosa were routinely grown and 
maintained in Luria–Bertani (LB) medium.  Ampicillin at 100 µg/ml was supplemented in the 
growth medium when required for E. coli. The protein expression vector pBAD-HisE (32) was 
used in this study to clone and express recombinant DauB protein.  
 
3.2.2 Cloning, expression and purification of hexahistidine tagged DauB.  
The dauB gene excluding the translational stop codon was amplified from the genomic DNA of P. 
aeruginosa PAO1 wild type using the primers DauB-HisCF: 5’-
CGCTCATGAGCGCCGCCACTCCC-3’ and DauB-HisCR: 5’-
TCCCCCGGGGCCTGCCTGGCGCAGGCG-3’. The resulting PCR fragments were digested 
with BspHI/SmaI restriction enzymes and cloned into pBAD HisE plasmid vector (31) so that the 
C-terminus of DauB was fused in-frame with the His6-tag while the N-terminus is preceded by a 
ribosome binding site and an arabinose-inducible promoter in the plasmid. pDAUB was introduced 
into E. coli Top10 (Invitrogen). For overexpression of DauB-HisC, the recombinant strains of E. 
coli were grown in LB medium containing ampicillin at 37°C. For over expression, 0.2 % L-
arabinose (w/v) was added to the culture when the OD600 was approximately 0.5-0.6. After 4 h of 
vigorous shaking at 37 °C, cells were harvested by centrifugation and stored at -80 °C until use.  
The cell pellets were suspended in phosphate buffer A (20 mM Na2HPO4, 0.5 M NaCl, 20 mM 
imidazole, pH 7.5) with PMSF (1 mM) as a protease inhibitor and the cells were ruptured by an 
Aminco French press. Cell debris was removed by centrifugation at 30,000 g for 30 min. The 
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supernatant was applied to a HisTrap HP column (GE Health Care) and the His-tagged DauB was 
eluted at 20-60 % buffer B (20 mM Na2HPO4, 0.5 M NaCl, 1 M imidazole, pH 7.5). The target 
fractions were analyzed by SDS-PAGE, pooled and concentrated using an Amicon Ultra-15 
centrifugal filter unit (molecular mass cut-off, 30 kDa; Millipore) to change the buffer to 20 mM 
Tris-HCl (pH 7.5). Protein concentration was determined by the method of Bradford (27). 
 
3.2.3 DauB enzyme assay.  
DauB enzyme activity was measured using the reverse reaction as described earlier (31, 33). L-
Arg was used as the substrate and the formation of NADH was measured at 340 nm using Cary 
3E (Varian). The reaction mixture contained L-Arg, NAD+, and purified DauB in 50 mM Tris-
HCl in a total volume of 2 ml. The reaction mix lacking L-arginine, NAD+ or DauB-HisC was pre-
incubated at 37 °C. The reaction was initiated by adding the missing component and followed for 
up to 15 min.  
 
3.3 Results 
 
3.3.1 DauB pH profile.  
Little to no enzyme activity, as determined by the formation of NADH, was detected at near 
neutral pH. As the pH increased, the enzyme activity increased and peaked at pH 9.0 and then 
started to reduce (Figure 3.3). Hence, pH 9.0 was taken as the optimal pH for the DauB 
enzymatic reaction and was used for all subsequent assays.  
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Figure 3.3 DauB pH profile.  
Each reaction included 141 µg of purified DauB-HisC, 10 mM L-Arg, 0.5 mM NAD+, 50mM Tris-
HCl (pH 7, 7.5, 8, 8.5, 9, 9.5 and 10) in 2 ml. The reaction was followed for 5 min after adding the 
amino acid at 37°C to the pre-incubated reaction mixture.  
  
3.3.2 DauB enzyme activity with varied enzyme concentrations.  
In order to find the optimal enzyme concentration under the given experimental conditions, DauB 
enzyme activity was measured with fixed concentrations of L-Arg (10 mM), NAD+ (0.5 mM) and 
varied enzyme concentration. The reaction was initiated by the addition of the enzyme to the pre-
warmed reaction mix and the reaction was followed for 5 min by measuring the formation of 
NADH. It was found that 70.5 µg of DauB-HisC gives a reaction velocity in the linear range 
(Figure 3.4). Hence this concentration was used for further analyses.  
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Figure 3.4 DauB enzyme activity with varied enzyme concentrations. 
Each reaction included DauB-HisC (23.7, 47, 70.5, 94, 117.5, 141, 164.5, 188, 211.5 and 235 µg), 
10 mM L-Arg, 0.5 mM NAD+ and 50 mM Tris-HCl pH 9 in 2 ml. The reaction was followed for 
5 min at 37 °C after adding enzyme to the pre-incubated reaction mix. 
  
3.3.3 DauB enzyme activity with varied L-arginine concentrations.  
This experiment was conducted to find the kinetic parameters for L-Arg used in the reaction. The 
reaction was initiated by the addition of the enzyme to pre-incubated reaction mix and was 
followed for 5 min.  It was found that the Km was 15.45 mM of L-Arg and the Vmax for DauB 
under these reaction conditions was 1.03 µM/S (Figure 3.5).  
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Figure 3.5 DauB enzyme activity with varied L-arginine concentrations. 
Each reaction included L-Arg (1, 2, 2.5, 5, 7.5, 10, 12.5, 15, 17.5, and 20 mM), 70.5 µg of DauB-
HisC, 0.5 mM NAD+, 50 mM Tris-HCl pH 9 in 2 ml. Each reaction was followed for 5 min after 
the addition of enzyme to the pre-incubated reaction mix. 
 
 
3.3.4 DauB enzyme activity with varied NAD+ concentrations.  
This experiment was conducted to find the kinetic parameters for NAD+ used in the reaction. The 
reaction was initiated by the addition of the enzyme to pre-incubated reaction mix and was 
followed for 5 min.  The concentration of L-Arg used in this reaction was increased to 40 mM 
from 10 mM based on the calculated Km for L-Arg It was found that the Km was 1.88 mM of 
NAD+ and the Vmax for DauB under these reaction conditions was 0.80 µM/S (Figure 3.6).            
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Figure 3.6 DauB enzyme activity with varied NAD+ concentrations. 
Each reaction included NAD+ (0.5, 1, 2, 3, 4, 5, 10, 15 and 20 mM), 70.5 µg of DauB-HisC, 40 
mM L-Arg, 50 mM Tris-HCl pH 9 in 2 ml. Each reaction was followed for 5 min after the addition 
of enzyme to the pre-incubated reaction mix. 
 
 
3.3.5 Substrate specificity of DauB.  
DauA was shown to utilize a number of D-amino acids very well as its substrate. Since DauBA 
are coupled dehydrogenases, we set to determine if DauB will complement the substrate specificity 
shown by DauA. Each reaction was initiated by the addition of the addition of DauB to pre-
incubated reaction mix and was followed for 15 min. It was found that unlike its partner enzyme 
DauA, DauB can utilize only L-Arg as a good substrate (Figure 3.7). Hence, DauB is an arginine-
specific dehydrogenase enzyme.  
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Figure 3.7 In vitro substrate specificity of DauB enzyme. 
Each reaction included 70.5 µg of DauB-HisC, 0.5 mM NAD+, 10 mM L-amino acid, 50 mM Tris-
HCl pH 9.0 in 2 ml. The reaction was followed for 15 min after adding DauB at 37 °C to the pre-
incubated reaction mixture. 
 
 
3.4 Discussion 
 
3.4.1 DauB is an arginine-specific dehydrogenase.  
In order to identify the optimal reaction conditions and kinetic parameters, we used purified C-
terminal hexahistidine tagged DauB enzyme. As shown in Figure 2.3, at pH 9.0, DauB exhibited 
maximal enzyme activity under our experimental conditions. The Km value for L-Arg was 15.45 
mM using 70.5 µg of DauB and 0.5 mM of NAD+ and the Vmax for DauB under these reaction 
conditions was 1.03 µM/S (Figure 2.5). The Km of NAD+ was 1.88 mM 70.5 µg of DauB and 
40mM L-Arg and the Vmax for DauB under these reaction conditions was 0.8µM/S (Figure 3.6). 
DauB showed relatively little to no activity using other L-amino acids as substrates (shown in 
Figure 3.7) as compared to that against L-Arg (taken as 100%). This indicates that DauB is an 
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arginine-specific dehydrogenase unlike its partner, DauA dehydrogenase, which can utilize a 
number of D-amino acids as the substrate (Figure 3.2). In addition, it is very likely that the 
potential DauAB complex is either formed in presence of D-Arg only or is limited to the 
racemization of D-Arg to L-Arg considering that these two enzymes vary widely in their 
substrate specificity.   
 
Transcription of the dauBAR operon is induced by D-Arg and D-Lys and this is further enhanced 
by L-Arg in the presence of ArgR (33). Even though DauA was shown to utilize a number of D-
amino acids as its substrates in vitro, only utilization of D-Arg as carbon and or nitrogen source 
was abolished in the dauA mutant (33). In the case of DauB, in agreement with the in vitro 
enzymatic assays in the current study and the previous studies (31), the dauB mutant can utilize 
D-Arg as a nitrogen source but not as carbon. All these support the unique role of DauBA in D-
Arg catabolism.       
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4 IN VIVO SUBSTRATE SPECIFICITY OF D-AMINO ACID DEHYDROGENASES 
IN PSEUDOMONAS AERUGINOSA PAO1 
 
4.1 Introduction 
 
D-amino acids are formed by racemization from cognate L-enantiomers. Until recent times the 
physiological importance of D-amino acids was not well known other than the presence of D-Ala 
and D-Glu in bacterial cell wall. However, recent studies revealed that the D-amino acids play 
many other important functions. Gramicidin is an antimicrobial peptide produced by Bacillus 
brevis that contains D-amino acids (4). DadA, D-alanine dehydrogenase, is involved in multiple 
virulence factor production in P. aeruginosa (43). In addition, many groups have demonstrated 
that D-amino acids can be detrimental to the cell. D-amino acids in combination with β-lactam 
antibiotics were shown to alter cell morphology (1). Bacillus subtilis was shown to produce a 
mixture of D-Leu, D-Met, D-Tyr and D-Trp that prevented biofilm formation and also disassemble 
existing biofilms (26). Lam et al., (28) found unusual D-amino acids in Vibrio cholerae and 
Bacillus subtilis that seemed to modify the cell wall in stationary phase cultures. D-amino acids 
given in combination with antimicrobials has a synergistic effect on biofilm dispersal in some 
isolates of P. aeruginosa and Staphylococcus aureus (52)  
 
P. aeruginosa PAO1 has three known D-amino acid dehydrogenases. D-Arginine dehydrogenase 
encoded by the gene dauA is part of a two-component racemase that converts D-arginine to L-
arginine (31, 33). This gene is indispensable for the utilization of D-Arg in PAO1. It was shown 
to utilize a number of D-amino acids as the substrate in vitro. D-Alanine dehydrogenase encoded 
by dadA gene is involved in the conversion of D-Ala to pyruvate and ammonia and was also shown 
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to utilize many D-amino acids as its substrate. DadA is essential for the utilization of D-Ala, D-
Val, D-Ser, D-Thr, D-Phe and D-His in PAO1. Although the dadA promoter is induced by several 
L-amino acids and by D-Ala, L-Ala was proposed as the signaling molecule for its transcriptional 
regulator DadR (19). D-Glutamate dehydrogenase encoded by the gene dguA is involved in the 
deamination of D-Glu and D-Gln (20). These three gens are essential for the utilization of the 
above mentioned D-amino acids as carbon and nitrogen sources. Since, the natural occurrence of 
D-amino acids is much less compared to the L-forms, we hypothesized that there could be a much 
important role for these dehydrogenases other than aiding the cell utilize these D-amino acids as 
nutrient sources. We hypothesized that the lack of the dauA, dadA, and dguA genes might weaken 
the cell and make it more susceptible to antibiotics when given in combination with D-amino acids.  
 
4.2 Materials and methods 
 
4.2.1 Strains and growth conditions.  
Bacterial strains used in this study were listed in Table 3.1. Luria–Bertani (LB) medium was used 
for bacterial growth with the following supplements as required: ampicillin at 100 µg/ml, 
carbenicillin at 100 µg/ml for E. coli, and streptomycin at 500 µg/ml and gentamicin at 30 µg/ml 
for P. aeruginosa. Minimal medium P (MMP) supplemented with specific carbon sources and 
nitrogen sources was used for the growth of P. aeruginosa (17).  
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Table 4.1 Bacterial strains and plasmids used in this study. 
Strain or plasmid Genotype or description Source 
E. coli   
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rK–, mK+) phoA 
supE44 λ– thi- 
1 gyrA96 relA1 
Bethesda 
Research 
Laboratories 
TOP10 F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1araD139 Δ(ara leu) 7697 galU 
galK rpsL 
(StrR) endA1 nupG 
Invitrogen 
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu 
(Kmr) 
(56) 
P. aeruginosa   
PAO1 Wild type (18) 
PAO1-Smr Spontaneous Smr mutant strain of PAO1 (23) 
PAO5731 ΔdguA (20) 
PAO5434  ΔdguA; ΔdadA; ΔdauA This study 
Plasmids   
pRTP2 Ampr Sms conjugation vector derived from pRTP1 (31) 
pPS856 Ampr, Gmr cloning vector (22) 
pFLP2 Ampr, sacB+ containing broad host range cloning 
vector 
(22) 
pUCP18 Escherichia-Pseudomonas shuttle vector (55) 
pRTP2 
ΔdauA::Gm 
pRTP2 with upstream and downstream of dauA 
linked by Gm cassette from pPS856 
This study 
pRTP2 
ΔdadA::Gm 
pRTP2 with upstream and downstream of dadA 
linked by Gm cassette from pPS856 
This study 
pUCP18DguA pCUP18 derivative carrying the dguA gene This study 
pUCP18DauA pCUP18 derivative carrying the dauA gene Congran Li (CR5.1) 
pUCP18DauBA pCUP18 derivative carrying the dauBA genes This study 
pUCP18DadA pCUP18 derivative carrying the dadA gene This study 
Smr, streptomycin resistance; Ampr, ampicillin resistance; Gm, gentamicin resistance; sacB+, 
sucrose-sensitive 
 
4.2.2 Construction of D-amino acid dehydrogenase triple mutant.  
A ΔdguA, ΔdadA, and ΔdauA triple mutant of PAO1 devoid of the three D-amino acid 
dehydrogenases, was constructed using a markerless gene deletion technique described 
previously (22). PAO5731 (ΔdguA), a derivative of PAO1 was used as the host to construct this 
triple dehydrogenase mutant. Briefly, the flanking regions of the dauA or dadA were amplified 
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by PCR, and restriction enzymes sites were introduced into the primers so that the PCR products 
possess configurations of 5′-BamHI-[left arm]-SmaI-3′ and 5′-SmaI-[right arm]- HindIII-3′. A 
1.6-kb EcoRI fragment containing the gentamicin resistance (Gmr) cassette was excised from the 
plasmid pPS856 by digesting with SmaI. After restriction enzyme digestion, these three DNA 
fragments were ligated and cloned into the BamHI and HindIII sites of pRTP2. The final plasmid 
construct was introduced into E. coli SM10 to serve as the donor in the biparental conjugation, 
with PAO1-Smr as the recipient. After incubation at 37 °C for 6 h, the transconjugants were 
spread and selected on LB plates supplemented with streptomycin and gentamicin. The protocol 
for gene replacement and in vivo excision by the Flp-FRT recombination system was used to 
remove the gentamicin resistance marker facilitating the generation of unmarked mutants of 
PAO1 with deletions on multiple genes. Expected deletions in these mutants were confirmed by 
PCR and by growth in specific D-amino acids that require these genes for catabolism. 
 
4.2.3 Construction and verification of D-amino acid dehydrogenase 
complementation clones.  
The dguA, dadA, dauA or dauBA genes were amplified from the genomic DNA of PAO1 along 
with their ribosome binding site (RBS) and were cloned into pUCP18 plasmid vector. The 
recombinant plasmids were verified by DNA sequencing and introduced into the ΔdguA, ΔdadA, 
and ΔdauA triple mutant independently. Two single colonies of the triple mutant with or without 
the gene complementation clone were resuspended in phosphate buffered saline and inoculated 
into MMP broth supplemented 20 mM L-Glu/10 mM D-Glucose + 10 mM D-Glu, D-Arg or D-
Ala/20 mM D-Glu, D-Arg or D-Ala for carbon and or nitrogen sources.  Growth was followed 
by visual inspection for turbidity at 37 °C, 300 rpm for up to 3 days. 
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4.2.4 Determination of MIC for wild-type PAO1 and the ΔdguA, ΔdadA, and 
ΔdauA triple mutant.  
Minimal inhibition concentrations (MICs) of antibiotics was determined by a liquid 
microdilution method according to the guidelines of the Clinical and Laboratory Standards 
Institute (8). Serial two-fold dilutions of the antibiotics in LB broth were prepared in a 96-well 
microtiter plate. LB broth without any antibiotic was used for both positive (inoculated) and 
negative (uninoculated) controls. Fresh overnight cultures of wild-type PAO1 and the ΔdguA, 
ΔdadA, and ΔdauA triple mutant (two independent cultures each) were diluted and inoculated 
with approximate 5 x 104 CFU/well. Cells were incubated without shaking at 37 ºC for 24 h. The 
lowest concentration of antimicrobial agent at which cells were not able to grow was defined as 
its MIC.  
 
4.2.5 In vivo substrate specificity of D-amino acid dehydrogenases.  
MMP broth supplemented with various D-amino acids as C and N source (20 mM) or as N 
source (5 mM) were prepared. When testing for nitrogen utilization, 10 mM D-Glucose was 
supplemented as a carbon source. The pH of the final medium was neutralized using HCl or 
NaOH. About 5 x 104 CFU of wild-type PAO1 and the ΔdguA, ΔdadA, and ΔdauA triple mutant 
with or without the gene complementation clones (two independent cultures for each genotype 
tested) were inoculated. MMP medium with 10 mM D-Glucose and 0.5 % NH4Cl was used as 
positive (inoculated) and negative (un-inoculated) controls. The plates were incubated at 37 °C 
and growth was noted by visual inspection 2 and 4 days post-inoculation.  
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4.2.6 Effect of D-amino acids given in conjunction with antibiotics.  
LB medium was supplemented with 5 mM of various D-amino acids in combination with 1X, 
0.5X or 0.25X MIC of carbenicillin, gentamicin or tetracycline. About 5 x 104 CFU of wild-type 
PAO1 or the ΔdguA, ΔdadA, and ΔdauA triple mutant were inoculated into each well. The plates 
were incubated at 37 °C and growth was recorded by measuring OD600 24 h post-inoculation. LB 
medium without any antibiotic or D-amino acid was used as positive control while the same 
without any bacterial cells served as negative control. 
 
4.3 Results 
 
4.3.1 Verification of ΔdguA, ΔdadA, and ΔdauA triple mutant.  
The triple mutant was tested for the loss of dauA, dadA, and dguA genes by PCR. The loss of 
these three genes was confirmed by testing the ability of the wild-type PAO1 and the triple 
mutant to utilize D-Glu, D-Arg and D-Ala as sole carbon and or nitrogen sources in minimal 
medium P. The wild-type PAO1 was able to utilize all the three D-amino acids tested as both 
carbon and nitrogen sources. The triple mutant could not use any of these compounds as either 
carbon or nitrogen sources indicating the loss of dauA, dadA, and dguA genes as expected. The 
gene organization of the three dehydrogenase genes in wild-type PAO1 and the ΔdguA, ΔdauA, 
and ΔdadA triple mutant along with the gene complementation clones is shown in Figure 4.1 
below. 
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Figure 4.1 Dehydrogenase gene organization and gene complementation. 
(a) Organization of the three dehydrogenase genes in wild-type PAO1. The dashed outline 
indicates the genomic region deleted in each locus to construct the ΔdguA, ΔdauA, and ΔdadA 
triple mutant. (b) Gene complementation clones constructed in the pUCP18 plasmid to 
complement each dehydrogenase gene in the ΔdguA, ΔdauA, and ΔdadA triple mutant. 
 
4.3.2 D-amino acid dehydrogenase gene complementation.  
In order to test for the in vivo substrate specificity of the D-amino acid dehydrogenases, gene 
complementation clones were constructed using the pUCP18 plasmid, an E. coli-Pseduomonas 
shuttle vector. Each D-amino acid dehydrogenase was cloned along with its ribosome binding 
site such that the gene expression is driven by the lacZ promoter on the pCUP18 plasmid (see 
Figure 4.1). These plasmids can reach 10 to 25 copies per cell with constitutive expression in P. 
aeruginosa (14). During the testing of gene complementation, we observed that the 
complementation of dauA gene could only restore utilization of D-Arg as a nitrogen source. This 
could be due to a non-functional dauB gene or DauB protein which may have got disrupted in 
part during the deletion of dauA. Hence, the dauBA complementation clone was also included in 
the analysis. It was found that the dguA, dadA, dauA, and dauBA gene clones all were able to 
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support growth on D-Glu, D-Ala, and D-Arg, as anticipated indicating that the gene 
complementation worked. 
4.3.3 Antibiotic susceptibility of wild-type PAO1 and the ΔdguA, ΔdauA, and 
ΔdadA triple mutant.  
The susceptibility of wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA triple mutant were 
tested for the antibiotic commonly used in the laboratory. It was found that the ΔdguA, ΔdauA, 
and ΔdadA triple mutant had two-fold lower minimum inhibition concentration (MIC) for 
carbenicillin and tetracycline while gentamicin remained same as compared to the wild-type 
PAO1 (see Table 4.2). This supports our hypothesis that the triple mutant is weakened though by 
unknown mechanism(s).  
Table 4.2 MIC for wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA triple mutant. 
  
 Minimum inhibitory concentration (MIC) (µg/mL) 
Carbenicillin Gentamicin Tetracycline 
WT PAO1 64 8 16 
PAO5434 32 8 8 
 
4.3.4 In vivo substrate specificity of D-amino acid dehydrogenases.  
Previous studies used purified His-tagged proteins and tested the substrate specificity of D-amino 
acid dehydrogenases in vitro. Each D-amino acid dehydrogenase was shown to utilize more than 
one D-amino acid as the substrate. Hence, the mutant growth phenotypes may or may not be an 
accurate reflection of the in vivo characteristics of these enzymes.  Here, we tried to see the in 
vivo substrate specificity of the D-amino acid dehydrogenases. It was found that DadA can 
utilize D-Ala, D-Val, D-His, D-Lys, D-Arg, D-Ser, D-Pro, D-Met, and D-Phe as the substrates. 
DguA can utilize D-Glu, D-Gln, and D-Ser as substrates. DauA can utilize D-His, D-Orn, D-Lys, 
D-Arg, D-Pro, D-Met, and D-Phe as substrates (see Table 4.3).  
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Table 4.3 In vivo substrate specificity of D-amino acid dehydrogenases. 
The data represents at least two independent sets of culture under each condition tested. Inoculated 
and un-inoculated LB medium was used as the positive and negative controls (not shown in table). 
Results were observed 2 days and 4 days post inoculation. Growth is by + and – is no growth even 
after 4 days. The ++ sign indicates that these cells grew better than or on par with the wild-type by 
2 days itself indicating that the complemented gene enhances growth on that substrate. Grey 
colored cells indicate that the enzyme encoded by complemented gene can utilize that D-amino 
acid as a substrate. 
 
 Wild-type 
PAO1 
PAO5434 (ΔdguA, ΔdauA, and ΔdadA) + gene complement 
 None dguA dadA dauA dauBA 
 N CN N CN N CN N CN N CN N CN 
D-Ala + + - - - - + + - - - - 
D-Val + + - - - - + + - - - - 
D-Glu + + - - + + -  - - - - 
D-Gln + + + + ++ ++ + + + + + + 
D-His + - + - + - ++ - ++ - ++ - 
D-Asn + - + - + - + - + - + - 
D-Asp - - - - - - - - - - - - 
D-Orn + - - - - - - - + - + - 
D-Lys + - - - - - + - ++ - ++ - 
D-Arg + + - - - - + - ++ - ++ ++ 
D-Ser + - + - ++ - ++ + + - + - 
D-Thr + - + - + - + - + - + - 
D-Pro + - - - - - + - + - + - 
D-Met + - + - + - ++ - ++ - ++ - 
D-Phe + - + - + - + + + + + + 
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4.3.5 Effect of D-amino acids given in conjunction with antibiotics.  
Based on previous reports from various groups it was expected that D-amino acids might weaken 
the cell wall making it more permeable to antibiotics. Alternatively. the lack of the dguA, dadA, 
and dauA genes may also make the cell more resistant as a coping mechanism. When the cells 
were exposed to 1X MIC of carbenicillin, presence of D-Phe and D-Pro resulted in cell growth 
both in the wild-type PAO1 and the ΔdguA, ΔdauA and ΔdadA triple mutant. At lower 
concentrations of carbenicillin (0.5X and 0.25X MIC), both the wild-type and the triple mutant 
cells grew normally like the respective control groups. When the cells were exposed to 
gentamicin, growth was completely abolished at 1X MIC. Further, even at 0.5X MIC the 
presence of any D-amino acid tested resulted in complete growth inhibition both in the wild-type 
and the ΔdguA, ΔdauA, and ΔdadA triple mutant cells indicating synergy between gentamicin 
and D-amino acids. When the cells were exposed to tetracycline, growth was completely 
abolished at 1X MIC. Further both at 0.5X and 0.25X MIC, a significant growth reduction was 
noted both in the wild-type and the ΔdguA, ΔdauA, and ΔdadA triple mutant cells as compared to 
the respective control groups indicating synergy between tetracycline and the D-amino acids 
tested. However, no special synergistic or antagonistic effects were observed specifically in the 
ΔdguA, ΔdauA, and ΔdadA triple mutant as compared to the wild-type PAO1 when D-amino 
acids were given in combination with antibiotics (see Tables 4.4 and 4.5).  
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Table 4.4 Effect of D-amino acids given in conjunction with antibiotics in wild-type PAOI. 
MIC Antibiotic Wild-type PAO1 
  
Carbenicillin 
(µg/mL) Ala Val Glu Gln His Asn Asp 
Positive 
control 
1X 64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.62 
0.5X 32 0.34 0.29 0.38 0.41 0.88 0.46 0.37 0.55 
0.25X 16 0.24 0.23 0.28 0.40 0.28 0.27 0.21 0.53 
  
Carbenicillin 
(µg/mL) Orn Lys Arg Ser Thr Pro  Phe 
Positive 
control 
1X 64 0.00 0.00 0.00 0.07 0.02 0.91 0.32 0.46 
0.5X 32 0.44 0.73 0.82 0.18 0.25 0.33 0.27 0.57 
0.25X 16 0.24 0.23 0.32 0.27 0.18 0.25 0.25 0.50 
          
  
Gentamicin 
(µg/mL) Ala Val Glu Gln His Asn Asp 
Positive 
control 
1X 8 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.68 
0.5X 4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.66 
0.25X 2 0.62 0.41 0.47 0.53 0.61 0.62 0.70 0.80 
  
Gentamicin 
(µg/mL) Orn Lys Arg Ser Thr Pro  Phe 
Positive 
control 
1X 8 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.73 
0.5X 4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.65 
0.25X 2 0.57 0.68 0.43 0.40 0.51 0.66 0.45 0.89 
          
  
Tetracycline 
(µg/mL) Ala Val Glu Gln His Asn Asp 
Positive 
control 
1X 16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.83 
0.5X 8 0.15 0.34 0.43 0.38 0.21 0.01 0.00 0.75 
0.25X 4 0.42 0.38 0.57 0.47 0.45 0.33 0.22 0.85 
  
Tetracycline 
(µg/mL) Orn Lys Arg Ser Thr Pro  Phe 
Positive 
control 
1X 16 0.00 -0.01 0.00 0.00 0.00 0.00 -0.01 0.89 
0.5X 8 0.40 0.13 0.10 0.19 0.00 0.25 0.12 0.75 
0.25X 4 0.61 0.34 0.33 0.32 0.47 0.50 0.38 1.10 
About 5 x 104 cells of WT PAO1 were inoculated into LB broth supplemented with 5 mM of 
various D-Amino acids in combination with 1X, 0.5X or 0.25X MIC of carbenicillin, gentamicin 
or tetracycline. The 96-well plates were incubated at 37 °C and growth was recorded by 
measuring OD600 24 h post inoculation. These results are an average of two independent sets of 
culture under each condition. LB medium without any antibiotic or D-amino acid was used as 
positive control. Negative control (not shown in table) was LB medium without any antibiotic, 
D-amino acid or bacterial cells.  
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Table 4.5 Effect of D-amino acids given in conjunction with antibiotics in ΔdguA, ΔdauA, 
and ΔdadA triple mutant. 
MIC Antibiotic  PAO5434 (ΔdguA, ΔdauA, and ΔdadA) 
  
Carbenicillin 
(µg/mL) Ala Val Glu Gln His Asn Asp 
Positive 
control 
1X 32 0.01 0.13 0.20 0.12 0.00 0.00 0.01 0.71 
0.5X 16 0.19 0.22 0.28 0.16 0.21 0.25 0.41 0.87 
0.25X 8 0.44 0.51 0.43 0.37 0.36 0.52 0.59 0.89 
  
Carbenicillin 
(µg/mL) Orn Lys Arg Ser Thr Pro  Phe 
Positive 
control 
1X 32 0.06 0.00 0.04 0.07 0.01 0.10 0.42 0.43 
0.5X 16 0.47 0.22 0.16 0.30 0.28 0.44 0.27 0.42 
0.25X 8 0.77 0.55 0.56 0.63 0.64 0.69 0.58 0.44 
          
  
Gentamicin 
(µg/mL) Ala Val Glu Gln His Asn Asp 
Positive 
control 
1X 8 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.82 
0.5X 4 0.10 0.09 0.11 0.15 0.01 0.04 0.01 0.86 
0.25X 2 0.30 0.33 0.40 0.41 0.43 0.33 0.39 0.84 
  
Gentamicin 
(µg/mL) Orn Lys Arg Ser Thr Pro  Phe 
Positive 
control 
1X 8 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.83 
0.5X 4 0.04 0.06 0.02 0.07 0.14 0.03 0.05 0.86 
0.25X 2 0.43 0.33 0.32 0.35 0.36 0.40 0.30 0.84 
          
  
Tetracycline 
(µg/mL) Ala Val Glu Gln His Asn Asp 
Positive 
control 
1X 8 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.93 
0.5X 4 0.11 0.17 0.29 0.33 0.35 0.14 0.43 0.97 
0.25X 2 0.49 0.49 0.49 0.50 0.58 0.53 0.43 0.92 
  
Tetracycline 
(µg/mL) Orn Lys Arg Ser Thr Pro  Phe 
Positive 
control 
1X 8 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.95 
0.5X 4 0.28 0.26 0.22 0.20 0.16 0.33 0.36 0.96 
0.25X 2 0.48 0.51 0.44 0.47 0.54 0.50 0.38 0.95 
About 5 x 104 CFU of ΔdguA, ΔdauA, and ΔdadA triple mutant cells were inoculated into LB 
broth supplemented with 5 mM of various D-Amino acids in combination with 1X, 0.5X or 
0.25X MIC of carbenicillin, gentamicin or tetracycline. The 96-well plates were incubated at 37 
°C and growth was recorded by measuring OD600 24 h post inoculation. These results are an 
average of two independent sets of culture under each condition. LB medium without any 
antibiotic or D-amino acid was used as positive control. Negative control (not shown in table) 
was LB medium without any antibiotic, D-amino acid or bacterial cells. 
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4.4 Discussion 
 
4.4.1 In vivo substrate specificity of the D-amino acid dehydrogenases.  
The in vivo substrate specificity of the D-amino acid dehydrogenase is different from that 
reported using in vitro studies.  
 
Table 4.6 In vitro and in vivo substrate specificities of D-amino acid dehydrogenases. 
Enzyme Amino acids that 
induce transcription 
In vitro D-amino acid 
specificity of enzyme  
In vivo D-amino acid 
utilization observed (this 
study) 
DguA D-Glu, D-Gln Glu, Gln, Pro Glu, Gln, Ser 
DadA L-Ala, L-Val, L-Trp, 
L-Ser, L-Thr, L-Lys, 
L-Gly, L-Cys, D-Ala, 
D-Thr 
Ala, Arg, Asn, Asp, His, Leu, 
Lys, Met, Orn, Phe, Pro, Ser, 
Thr, Trp, Tyr, Val 
Ala, Val, His, Lys, Arg, 
Ser, Pro, Met, Phe 
DauA D-Arg, D-Lys Arg, Lys, Met, Phe, Tyr, His, 
Orn, Leu, Trp, Val, Pro, Thr, 
Asn, Glu, Gln, Ala 
His, Orn, Lys, Arg, Pro, 
Met, Phe 
The in vitro substrate specificities were pooled from previously published reports (19, 20, 33) 
and the in vivo substrate specificities are from this study. The amino acids that are utilized by 
each enzyme either only in vitro or in vivo are highlighted with a gray background. D-Trp and D-
Tyr were not tested in vivo and hence not highlighted. 
 
Purified His-tagged DguA was shown to utilize D-Glu, D-Gln and D-Pro in vitro (20). However, 
in our study using in vivo gene complementation, it was found that DguA can utilize D-Glu, D-
Gln, and D-Ser as substrates.  DadA was shown to utilize 16 of the 18 D-amino acids tested in 
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vitro (19). But, we found that in vivo substrate utilization by DadA is limited to D-Ala, D-Val, 
D-His, D-Lys, D-Arg, D-Ser, D-Pro, D-Met, and D-Phe. Similarly, DauA was also shown to 
utilize 9 D-amino acids very well, 9 other somewhat poorly (31). However, we found that DauA 
can utilize D-His, D-Orn, D-Lys, D-Arg, D-Pro, D-Met, and D-Phe as substrates (see Table 4.7). 
Overall, the enhanced growth on D-amino acids by the presence of recombinant clones was due 
to increased levels of enzymes with broad substrate specificity. In the wild type strain, 
expression of these enzymes is subjected to induction by specific D-amino acids or related 
compounds. However, expression of these enzymes is constitutively active from the recombinant 
clones. 
 
4.4.2 Utilization of other D-amino acids.  
If the wild type strain needed to convert D to L via the traditional racemase, then utilization of D 
amino acids will not be affected in the triple mutant. Both the wild-type PAO1 and the ΔdguA, 
ΔdauA, and ΔdadA triple mutant were able to utilize D-Gln as the sole source of carbon and 
nitrogen while D-His, Asn, Ser, Thr, Met and Phe served only as a nitrogen source. D-Glutamine 
degradation can proceed in two possible ways: it can be converted into the L-form by a racemase 
or it can be directly deaminated to form glutamate and ammonia. In the case of the triple mutant, 
since D-glutamate degradation is abolished (requires DguA), I presumed that D-Gln is being 
converted into L-Gln by an unknown racemase followed by deamination to form L-Glu (a good 
carbon and nitrogen source for PAO1) and ammonia. However, enhanced growth by dguA gene 
complementation suggests that the alternate route is also possible. The utilization of D-Asn could 
be following similar suite. Both L-Gln and L-Asn can be deaminated by the glutaminase and 
asparaginase enzymes to remove the amine group and produce L-Glu and L-Asp respectively. 
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Both these enzymes have been previously detected and purified from Pseudomonads and PAO1 
has two genes (ansA and ansB) that have high sequence similarity to the glutaminase and 
asparaginase enzymes (59, 11, 12). Utilization of D-Ser and D-Thr can be attributed to D-Ser 
dehydratase even though dadA gene complementation enhanced growth on D-Ser as nitrogen. In 
E. coli, D-Met was suggested to be converted into keto-methionine and then into L-Met (9). The 
arginine: pyruvate transaminase AruH of P. aeruginosa PAO1 was shown to utilize L-Met as a 
substrate (64). Even though not studied experimentally, it is possible that AruH is responsible for 
the utilization of D-Met as a nitrogen source in the triple mutant. However, as demonstrated by 
others previously we also observed an enhanced growth on D-Met when complemented by dadA 
and dauA genes. In case of D-His, even though dadA and dauA gene complementation seemed to 
contribute to its utilization as a nitrogen source, there are other unknown enzymes that we are not 
aware of allowing the triple mutant to harvest nitrogen from D-His. The wild-type and ΔdguA, 
ΔdauA, and ΔdadA triple mutant strains were able to utilize D-Phe as only a nitrogen source 
indicating the involvement of another unknown enzyme. dadA and dauA or dauAB gene 
complementation allowed the triple mutant to utilize D-Phe as both carbon and nitrogen sources 
confirming previous reports (19, 31). The wild-type PAO1 was also able to utilize D-Pro as a 
nitrogen source which was completely abolished in the ΔdguA, ΔdauA, and ΔdadA triple mutant. 
Complementation with any of the three dehydrogenase genes did not restore the utilization of D-
Pro. D-Pro utilization was shown to be dependent on the dpkA gene in P. putida. Since the dpkA 
gene was not mutated, it is not clear as to why the utilization D-Pro was abolished in the ΔdguA, 
ΔdauA, and ΔdadA triple mutant (38). 
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4.4.3 The triple mutant is weakened by an unknown mechanism.  
The triple dehydrogenase mutant is weakened by an unknown mechanism. As a result, the triple 
mutant exhibited increased susceptibility to some of the common laboratory antibiotics. Both for 
Carbenicillin and tetracycline, the triple mutant had two-fold lower MIC than the wild-type 
PAO1. The mechanism by which the loss of dauA, dadA, and dguA genes affects the cell is yet to 
be studied. This might pave way for better strategies to combat P. aeruginosa infections.  
 
4.4.4 No special synergy was observed between D-amino acids and antibiotics 
against the triple mutant.  
Previous studies by other groups showed that D-amino acids can be detrimental to the cell and 
exhibit synergy with β-lactam antibiotics (3, 52).  A mixture of D-amino acids was shown to 
prevent biofilm formation (26) and modify cell wall (28). In addition, excessive D-amino acids in 
the cell if not effectively removed or utilized, can also be wrongly charged on the tRNA’s and 
there by stall protein synthesis. We hypothesized that deletion of all the three D-amino acid 
dehydrogenases would weaken the cell or make it more resistant. We also hypothesized that the 
addition of D-amino acids to the triple mutant in combination with antibiotics would have a 
synergistic or antagonistic effect in inhibiting the growth of PAO1. True to our hypothesis, we did 
observe that the triple mutant had lowered tolerance for antibiotics compared to the wild-type 
PAO1. When the cells were exposed to 1X MIC of carbenicillin, presence of D-Phe and D-Pro 
resulted in cell growth in both the wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA triple 
mutant. In the case of gentamicin and tetracycline, the presence of D-amino acids made the cells 
more susceptible to these antibiotics. Complete growth inhibition was observed even at 0.5X MIC 
when gentamicin was given in combination with any of the D-amino acids tested. In the case of 
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tetracycline, a significant growth reduction was noted at 0.5X and 0.25X MIC when given in 
combination with any of the D-amino acids tested. This synergy between gentamycin or 
tetracycline and D-amino acids was noted in both the wild-type and the ΔdguA, ΔdauA, and ΔdadA 
triple mutant cells. However, no special synergistic or antagonistic effects were observed 
specifically in the ΔdguA, ΔdauA, and ΔdadA triple mutant as compared to the wild-type PAO1 
when D-amino acids were given in combination with antibiotics.  
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5 GENERAL CONCLUSION 
P. aeruginosa, an opportunistic human pathogen, is also well known for its enormous metabolic 
capacity making it a model organism to study nutrient utilization genes and pathways. In 
addition, owing to its resistance to multiple antibiotics, the pursuit of new targets for potential 
antibiotic development has been of great interest in this organism. In this dissertation, we studied 
the lysine catabolic pathway to identify the missing players. We have shown that the gcdGH 
genes encoding glutaryl-CoA dehydrogenase and as putative acyl-CoA transferase, respectively, 
are essential for lysine catabolism. Transcription of this operon is activated by GcdR in the 
presence of glutarate and we showed the possible GcdR binding site on the gcdH promoter DNA. 
Though glutarate is an intermediate compound of L-lysine catabolism, the gcdG and gcdH 
mutants cannot grow on L-Pip, a D-lysine metabolite, suggesting that L-Pip is also degraded via 
glutarate. This is the first link indicating that L-and D-lysine catabolic pathways are connected. 
We further showed that PA2035 is induced by D-Lys and L-pip and mutants of this gene cannot 
grow on L-Pip. We believe that PA2035 encoding a TPP-dependent decarboxylase is a possible 
player in the conversion of 2-aminoadipate to glutarate.  
 
There are multiple reasons that possibly contribute to lysine being a poor nutrient source in P. 
aeruginosa PAO1. Previous studies from our lab showed that lysine decarboxylase enzyme ldcA, 
the first enzyme in L-lys catabolism, is under the control of an arginine-responsive transcriptional 
regulator argR. In this study, we showed that lysine uptake and export are two other bottlenecks 
for growth on L-Lys. We found the lysXE operon encoding an uncharacterized protein and a 
putative lysine efflux protein is induced by exogenous L-Lys. This operon is under the 
transcriptional regulation of LysR and we have identified the LysR operator site on lysX promoter 
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DNA. Knockout mutants of lysR, lysX, and lysE were found to grow much better than the wild-
type PAO1 on MMP agar with L-Lys as the sole source of C & N and had a much shorter lag-
phase and generation time in liquid media. We believe that the shorter lag phase and generation 
time observed in lysR, lysX, and lysE mutants was due to the lack of a functional lysine exporter, 
resulting in a higher intracellular concentrations of L-Lys compared to the wild-type PAO1. In this 
study, we also showed that lysP mutant grew very poorly on L-lys compared to the wild type 
PAO1. Transcription of the lysP gene is positively regulated by aruSR that responds to L-Lys and 
L-Arg and negatively regulated by argR that responds to L-Arg making this another bottleneck for 
lysine catabolism. P. aeruginosa is well equipped to grow more efficiently on Arg than on Lys, 
with the ArgR regulator in response to L-Arg as the major player to control the entire arginine 
network. The physiological significance of this observed nutritional preference for Arg over Lys 
in Pseudomonas was a very intriguing question for future investigation. 
 
Previous studies from our lab showed that catabolic and anabolic dehydrogenases DauA and DauB 
are essential for D-to-L racemization of arginine which is a prerequisite for D-arginine utilization 
in P. aeruginosa PAO1. In addition to D-arginine, DauA can utilize D-Lys as a substrate to 
generate keto lysine or α-keto-ε-aminohexanoate which can further be degraded into L-Pip and so 
on. In this dissertation, we studied the substrate specificity of DauB to see if D-Lys can be 
racemized to L-Lys for catabolism. We also studied the enzyme kinetics of DauB. Using a reverse 
reaction to measure DauB activity, we found that DauB showed little or no activity against lysine 
or other L-amino acids as substrates as compared to that against L-Arg (taken as 100 %). This 
indicates that DauB is an arginine-specific dehydrogenase unlike its partner enzyme DauA 
eliminating the possibility of D-to-L racemization of Lysine for catabolism (there is no other lysine 
racemase in PAO1). 
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In bacteria, D-amino acids are formed by racemization from cognate L-enantiomers which is an 
energetically expensive process for the cell. P. aeruginosa PAO1 has three known D-amino acid 
dehydrogenases: dadA, dauA, and dguA. The in vitro substrate specificity of these three enzymes 
has been demonstrated by our lab previously. However, we do not know if these results are true 
and the only physiological functions of these enzymes. With the emerging understanding of the 
far more important functions of D-amino acids and some of these D-amino acid catabolizing genes 
in the bacterial world, it is intriguing to see if the D-amino acid dehydrogenase genes/enzymes 
also have a wider physiological implication. We hypothesized that the lack of dadA, dauA, and 
dguA genes might weaken the cell and make it more susceptible to antibiotics when given in 
combination with D-amino acids. We also tested the role of each of these dehydrogenases in the 
utilization of various D-amino acids in vivo. We found that the in vivo substrate specificity of the 
D-amino acid dehydrogenases is different from that reported using in vitro studies.  
 
The ΔdguA, ΔdauA, and ΔdadA triple dehydrogenase mutant is weakened by an unknown 
mechanism resulting in increased susceptibility to carbenicillin and tetracycline. The mechanism 
by which the loss of dauA, dadA and dguA genes affects the cell is yet to be studied. This might 
pave the way for better strategies to combat P. aeruginosa infections. At concentrations below 
the MIC, synergy was observed between gentamicin or tetracycline and D-amino acids resulting 
in growth inhibition or reduction, in the wild-type PAO1 and the ΔdguA, ΔdauA, and ΔdadA 
triple mutant, respectively. However, no special synergistic or antagonistic effects were observed 
specifically in the ΔdguA, ΔdauA and ΔdadA triple mutant as compared to the wild-type PAO1 
when D-amino acids were given in combination with antibiotics.  
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